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ZUSAMMENFASSUNG 
Die Regeneration von Organen bedarf einer physiologischen Balance zwischen Selbsterneuerung 
und Ausdifferenzierung von gewebespezifischen Vorläuferzellen, wobei die Expansion und 
Ausdifferenzierung dieser Vorläuferzellen zahlreiche Regulationsmechanismen der 
Embryonalentwicklung verlangt.  
High mobility group (HMG)-Proteine sind die häufigsten Vertreter innerhalb der Gruppe des 
Nicht-Histon-Chromatins assoziierten Proteine und treten verstärkt in verschiedenen, 
undifferenzierten Geweben während der Embryonalentwicklung auf. Im entsprechenden adulten 
Gewebe sind diese nur noch geringfügig vorhanden und für die Aufrechterhaltung und 
Aktivierung von Stamm- oder Vorläuferzellen verantwortlich. In der vorliegenden Studie wurde 
die Rolle des high mobility group AT-hook Proteins 2 (HMGA2) als Schlüsselmolekül während 
der Morphogenese, sowie während der Ausdifferenzierung des Epithels in der embryonalen als 
auch in der adulten Lunge  beschrieben. Durch detaillierte Analyse der Lunge von Hmga2-/- 
Mäusen in Kombination mit Experimenten ohne funktionierendes Hmga2 konnte eine verstärkte 
Signaltransduktion des kanonischen WNT-Signalwegs festgestellt werden, die nicht nur zur 
fehlerhaften Ausdifferenzierung des Epithels, sondern auch zu einem erhöhten Vorkommen von 
Bronchoalveolaren Stammzellen (BASCs) in der adulten Lunge führte. Durch die erhöhte 
Anzahl von Vorläuferzellen in den Lungen von Hmga2-/- Mäusen veränderte sich das 
Gleichgewicht zwischen Selbsterneuerung und Ausdifferenzierung, was in einer verminderten 
Anzahl von Typ2 Pneumozyten (ATII) resultierte und eine veränderte Lungenmorphologie, 
sowie Funktionalität zur Folge hat. Weiterhin zeigte, dass HMGA2 ein direkter Regulator von 
Gata6 ist, der eine entscheidende Transkcriptionsfaktor in der WNT-Signaltransduktion ist. 
Insgesamt konnte eine direkte transkriptionale Aktivierung von Gata6 durch HMGA2 beobachtet 
werden, wobei diese Aktivierung abhängig von der Phosphorylierung von S65 (H1S65ph) an 
Histon H1 sowie von S139 (H2AXS139ph) an Histon H2AX durch die Kinase Ataxia 
telangiectasia mutated (ATM) ist. Hierbei folgt  H2AXS139ph auf H1S65ph und erst im 
Anschluss finden der Abbau von Promoter-assoziierten Nukleosomen und die transkriptionale 
Aktivierung statt. Diese  Interaktionen von HMGA2, ATM, H1 und H2AX zeigen einen neuen 
Mechanismus für die Initiation der Transkription.  
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Zusammengefasst, demonstriert die vorliegende Studie,  dass HMGA2-vermittelte 
Veränderungen in der Chromatinstruktur die kanonische WNT-Signaltransduktion regulieren, 
wodurch das physiologische Gleichgewicht zwischen Expansion oder Differenzierung von 
Vorläuferzellen in Balance gehalten wird, was entscheidend für die Lungenentwicklung als auch 
für die Homöostase ist.   
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ABSTRACT 
Organ regeneration requires a proper balance between self-renewal and differentiation of tissue-
specific progenitor cells. Progenitor cell expansion and differentiation recapitulate many of the 
mechanisms regulating embryonic development. The high-mobility-group (HMG) proteins are 
the most abundant non-histone chromatin-associated proteins. They are present at high levels in 
various undifferentiated tissues during embryonic development and their levels are strongly 
reduced in the corresponding adult tissues, where they have been implicated in maintaining and 
activating stem/progenitor cells. Here, this study uncovered the role of the high mobility group 
AT-hook protein 2 (HMGA2) as a key regulator of branching morphogenesis and epithelial 
differentiation during embryonic lung development as well as in adult lung. Detailed analysis of 
the Hmga2 knockout (Hmga2-/-, KO) mice together with in vitro Hmga2 loss-of-function (LOF) 
experiments revealed enhanced canonical WNT signaling resulting not only in defective lung 
epithelial differentiation but also in increased numbers of bronchioalveolar stem cells (BASCs). 
Increased numbers of progenitor cells in the lung of Hmga2-/- mice generated an imbalance in 
cell differentiation that is reflected in a reduction of alveolar type II (ATII) cells, thereby 
affecting both lung morphology as well as lung functionality. It also showed that HMGA2 
directly regulates Gata6 which is crucial for fine-tuning canonical WNT signaling in airway 
epithelium.  
In addition, this study deciphered the molecular mechanism of transcriptional activation 
mediated by HMGA2. It showed that Hmga2-induced transcriptional activation of Gata6 
requires phosphorylation of the linker histone H1 at S65 (H1S65ph) and the core histone variant 
H2AX at S139 (H2AXS139ph), both mediated by the kinase, ataxia telangiectasia mutated 
(ATM). It also demonstrated the sequential order of events in which H1S65ph precedes 
H2AXS139ph and both are a prerequisite for the subsequent disassembly of promoter-associated 
nucleosomes and transcriptional activation. The functional interplay between HMGA2, ATM, 
H1 and H2AX is a novel mechanism of transcription initiation.  
Together, this data demonstrate that HMGA2-mediated changes in chromatin structure regulate 
canonical WNT signaling and control the balance between progenitor cells expansion and 
differentiation required for both lung development and homeostasis. 
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Chapter 1: INTRODUCTION 
 
 
In air-breathing vertebrates, lung is the essential respiratory organ where gas exchange occurs to 
bring in oxygen and to expel carbon dioxide. Therefore, it is constantly exposed to particulate 
matters, microorganisms and toxins from the environment. Thus, the alveolar epithelium, which 
represents 99% of the surface area of the lung, must execute simultaneously programs of oxygen 
provision for the entire body and of self-protection and repair. This implicates coordinated 
cellular and molecular processes allowing the maintenance of alveolar stability during breathing, 
through an organ regeneration process.  
1.1 Lung	Homeostasis	
 
Organ regeneration requires a proper balance between differentiation and self-renewal of tissue-
specific progenitor cells during both homeostatic turnover and repair after injury (Figure 1). The 
lung shows slow homeostatic turnover but rapid repair after injury. Tissue-resident lung-
endogenous progenitor cell niches are thought to be responsible for both processes [1-3]. 
 
 
 
 
 
Figure  1.  Schematic  representation  of 
Lung  progenitor/stem  cells  function. 
Adapted and modified [4]. 
 
 
 
The adult lung is a complex, integrated system of numerous types of specialized cells that 
originate from epithelial and mesenchymal cell lineages and are organized in a proximal-distal 
manner to make gas exchange possible. There are different progenitor cell niches in the lung 
located in specific regions along the proximal–distal axis of the airways (Figure 2) [1]. BASCs 
represent one of these regional progenitor cell populations and are located at the terminal ends of 
distal bronchioles in the bronchioalveolar duct junctions (BADJ) [5]. BASCs are responsible for 
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regeneration of bronchiolar and alveolar epithelium during homeostatic turnover and in response 
to injury [6]. Characterization of the regulatory mechanisms controlling the proper balance 
between expansion and differentiation of BASCs would make a profound impact on our 
understanding and treatment of lung diseases. Many of the mechanisms involved in regulating 
embryonic development are recapitulated in progenitor expansion and tissue regeneration. 
Therefore, new experimental approaches, especially those based on embryonic development 
studies, are needed to elucidate the transcriptional mechanisms and signaling pathways required 
to direct proper balance between differentiation and self-renewal of progenitor cells. 
 
Figure 2. Schematic representation of adult lung airways and the different cell types present in each region. Cells 
with stem cell potential are shown with red arrow. Adapted and modified [1, 7, 8].  
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1.2	Lung	Development	
 
The mouse lung arises from the anterior endoderm and forms during five overlapping phases of 
lung development: embryonic (E9.5-E12.5), pseudoglandular (E12.5-E16.5), canalicular (E16.5-
E17.5), saccular (E17.5-P5) and alveolar (P5-P28) (Figure 3) [9-11]. 
 
 
 
 
Figure  3.  The  stages  of 
mouse  lung development. 
E,  embryonic  day;  P, 
postnatal  day.  Adapted 
and modified [12].  
 
 
 
At the end of the embryonic phase, primary and secondary lung buds have formed and the 
establishment of proximal-distal axis has occurred from a morphologically uniform progenitor 
cell population. Later, the proximal embryonic progenitors give rise to proximal adult epithelium 
with the emergence of neuroendocrine, basal, ciliated and secretory cells while the distal tips of 
embryonic progenitors give rise to distal adult epithelium comprising of Alveolar Type I and 
Type II cells (Figure 4). 
Several evolutionarily conserved signaling pathways have been implicated in different phases of 
embryonic lung development. In particular, members of the fibroblast growth factor (FGF), bone 
morphogenetic protein (BMP), hedgehog/Gli, epidermal growth factor (EGF) and wingless 
secreted glycoproteins (WNT) families have been implicated in lung morphogenesis and 
epithelial differentiation [9, 13-16]. In addition, a well-organized and balanced interplay between 
these signaling pathways and key transcription factors of lung development, including NK2 
homeobox 1 (NKX2-1), Forkhead box protein A2 (FOXA2) and GATA binding protein 6 
(GATA6) is required for proper lung formation [9, 11, 16].  
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Figure 4. Lung at embryonic (A) and adult (B) stages. In the developing lung proximal progenitors (A) give rise to 
proximal  cells  lineages  observed  in  the  adult  lung  (B)  and  the  distal  tip  progenitors  (A)  contribute  to  the 
stereotypical  branching  morphogenesis  and  eventually  the  distal  respiratory  epithelial  cells  (B).  Adapted  and 
modified [17, 18].   
 
1.2.1	WNT	signaling	during	lung	development	
 
The WNT signaling pathways are the evolutionary conserved pathways that regulate cell fate 
determination, cell polarity, cell migration and organogenesis during embryonic development.  
They are subdivided into canonical WNT pathway (Figure 5), non-canonical planar cell polarity 
pathway and non-canonical WNT/calcium pathway [19].  
Canonical WNT signaling pathway is β-catenin (CTNNB1)-dependent WNT signaling pathway. 
In the absence of WNT ligands (Figure 5, left), the destruction complex (CKIα, GSK3β, APC, 
AXIN) hyperphosphorylates β-catenin. Hyperphosphorylated β-catenin is later ubiqitinated and 
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degraded by the proteosome. However, WNT ligands binding to a Frizzled/LRP (low-density 
lipoprotein receptor related protein)-5/6 receptor complex (Figure 5, right) leads to stabilization 
of hypo phosphorylated β-catenin, which translocate from cytosol to nucleus and interacts with 
T-cell factors (TCF) / Lymphoid enhancing factor (LEF) proteins to activate transcription of 
target genes.   
 
 
 
 
 
 
 
 
 
 
Figure  5.  Overview  of  a 
canonical  WNT  signaling 
pathway.   Adapted  and 
modified [20]. 
 
 
 
 
 
 
 
 
 
 
WNT signaling molecules such as Frizzled receptors (Fz-1, -2, -7), TCF (-1,-3,-4), LEF-1, WNT 
-2/2b, -11, -7b, -5a, and secreted Fz related proteins (sFrp-1, -2 and -4) are expressed during lung 
development in specific spatiotemporal patterns [21-24]. WNT signaling pathways are essential 
for proximal-distal patterning and for the specification of the proximal-distal cell fate during 
lung morphogenesis [25-27].  
1.2.2	GATA6	function	during	lung	development	
 
GATA6 is the only zinc finger transcription factor member of GATA family that is expressed in 
the distal epithelium of the developing lung [28, 29]. GATA6 is essential for branching 
morphogenesis and regulating differentiation of distal lung epithelium [29, 30]. Moreover, 
GATA6 positively regulates Fzd2 expression which results in blocking canonical WNT signaling 
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in lung epithelial cells to control the balance between BASCs expansion and lung epithelial 
differentiation [31].  
	1.3	HMG	proteins	
 
 
 
Figure  6. Genealogical  Tree of human HMG proteins. HMG 
proteins  are  divided  into  three  families  depending  on  their 
DNA binding domains: HMGA, HMGB and HMGN. CLUSTALW 
software used  to build rooted phylogenetic  tree with branch 
length  (UPGMA)  of  human  HMG  group  family  members. 
Adapted [32]. 
 
 
 
 
The genome of eukaryotic cells is highly organized and packed into chromatin. The nucleosome 
is the structural and functional unit of chromatin and consists of a nucleosome core particle, a 
linker histone of the H1 family and 20-30 base pair (bp) of linker DNA. The nucleosome core 
particle is built of 147 bp of DNA wrapped around a histone octamer, which is composed of two 
copies of each of the four core histones (H2A, H2B, H3 and H4). Histone H1 binds the linker 
DNA asymmetrically at the nucleosomal entry and exit sites, limiting the mobility of the 
nucleosome core particle and increasing the compactness of higher order chromatin [33]. In 
addition to nucleosomes, chromatin consists of non-histone chromatin-associated proteins, of 
which the HMG proteins are the most abundant. Based on their DNA binding domains, the HMG 
proteins are subdivided into three families (Figure 6): HMGA (containing AT-hooks), HMGB 
(containing HMG-boxes) and HMGN (containing nucleosomal binding domains) [33, 34]. HMG 
proteins can recognize structure rather than a particular nucleotide sequence and are able to bind 
to specific structures in DNA or chromatin in a sequence-independent manner via their 
respective functional motifs [35, 36]. Interestingly, HMG proteins are called architectural 
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transcription factors because, although they do not possess intrinsic transcriptional activity, they 
modulate transcription of their target genes by altering the chromatin structure at the promoter 
and/or enhancers [35, 37]. Here we deciphered the mechanism of transcriptional regulation 
mediated by the HMGA2, a HMGA family member and its implication during lung development 
and homeostasis.  
 
1.3.1	HMGA	
 
HMGA family comprises HMGA1a, HMGA1b, HMGA1c and HMGA2 (Figure 7). They are 
encoded by two distinct genes. The HMGA1 gene gives rise to three proteins (HMGA1a, 
HMGA1b and HMGA1c) by alternative splicing of a common transcript. With the exception of 
HMGA1c, the HMGA proteins contain three short basic repeats called AT-hook motif and a C-
terminal acidic tail (Figure 7) [38-41]. 
 
Figure  7.  Schematic  representations  of 
human  HMGA  proteins.  HMGA1a, 
HMGA1b,  HMGA1c  and  HMGA2  proteins 
contain  unique  AT‐hook  motif  (DNA 
binding domain  (DB), blue boxes) and a C 
terminal acidic domain (Ac‐T, pink boxes). 
The  amino  acid  sequence  of  HMGA1c 
differs from the one from HGMA1a and 1b 
starting  from  amino  acid  65  (green  box). 
Adapted [32]. 
 
 
 
The amino acid sequence of the AT-hook motif is K/RXRGRP (X = glycine or proline) and is 
flanked on each side by positively charged residues. These characteristics determine the binding 
preference of HMGA proteins to both the minor groove of AT-rich DNA stretches [42, 43] and 
to nucleosomes in a cooperative manner [44]. The function of the C-terminal acidic region is 
poorly understood. However, there are speculations that C-terminal acidic tail is involved in 
protein-protein interaction and recruitment of factors during regulation of gene transcription [45]. 
 
  
	 INTRODUCTION	
9
1.3.2	HMGA2	
 
HMGA2 is a nuclear non-histone chromatin associated protein. Its second AT-hook domain is 
required for nuclear localization [46]. This protein is conserved across the species (Figure 8). It 
is present at high level in various undifferentiated tissues during embryonic development and its 
level is strongly reduced or almost absent in the corresponding adult tissues [47-49]. In addition, 
HMGA2 is highly expressed in transformed cells in a variety of malignant and benign tumors of 
different origins [41, 50-55] suggesting its role during embryonic development and disease.  
Figure 8. Clustal 2.1 multiple sequence alignment  for HMGA2 across  the species. AT‐hook domain  is shown  in 
black  dotted  box  and  acidic  tail  is  shown  in  blue  dotted  box.  gi|6754210|ref|NP_034571.1|  HMGA2  [Mus 
musculus];  gi|166157846|ref|NP_001107346.1| HMGA2.1  [Xenopus  tropicalis];  gi|14091756|ref|NP_114459.1| 
HMGA2  [Rattus  norvegicus];  gi|47086681|ref|NP_997845.1|  HMGA2  [Danio  rerio]; 
gi|45384530|ref|NP_990332.1| HMGA2 [Gallus gallus]; gi|4504431|ref|NP_003474.1| HMGA2a [Homo sapiens].  
 
Hmga2 expression is regulated at transcriptional and post-trasncriptional level, for example 
transforming growth factor beta (TGF-β) and RAS-MAPK signaling pathways positively 
regulate Hmga2 expression at transcriptional level [56-58]. However, miRNAs such as let-7, 
miR-21, and miR-33a negatively regulate Hmga2 expression at post-transcriptional level [59-
62].  
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Hmga2-/- mice show a pygmy phenotype due to reduced expression of the insulin-like growth 
factor 2 mRNA binding protein 2 (Igf2bp2) gene [63-66]. They also show reduced fat tissue 
which is linked to a function of Hmga2 in pre-adipocyte precursor cell proliferation [49]. In 
addition, Hmga2-/- embryonic fibroblasts have a proliferative defect. A recent study had showed 
the Hmga2 importance for the self-renewal potential of hematopoietic stem cells [67]. On other 
hand, transgenic mice overexpressing a carboxyl-terminally truncated version of Hmga2 show a 
giant phenotype, are obese and develop lymphomas [68, 69]. It was shown that HMGA2 is 
necessary for the commitment of mouse embryonic stem cells to the skeletal muscle [48, 65] and 
cardiac muscle lineages [70]. HMGA2 proteins are also important for the proliferation of early 
stage neural precursor cells (NPCs) and for their neurogenic potential and overexpression of 
these genes can reprogram late stage NPCs into cells with early stage-specific capacities 
suppressing astrogenesis [71]. There is also report that Hmga2-/- mice show an impaired 
spermatogenesis and are sterile [47], thus HMGA2 protein is required for normal sperm 
development (Figure 9).     
 
 
Figure 9. Schematic 
representation  of 
HMGA2  role during 
cell  differentiation. 
HMGA2  protein  is 
required  for  proper 
development  and 
progenitor  cell 
differentiation  to 
adipocyte,  skeletal 
muscle,  cardiac 
muscle,  neurons, 
spermatozoids  and 
hematopoietic cells. 
Adapted [32]. 
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1.3.3	HMGA	and	Transcription	
 
In eukaryotes, two types of core promoters are used for gene transcription initiation: promoters 
that are enriched with the di-nucleotide sequence CpG and promoters that are CpG poor [72-74].  
CpG poor core promoters usually contain a TATA box, initiator sequences (INR), a transcription 
factor IIB recognition element (BRE) and downstream promoter elements (DPE) [75-77]. These 
promoters have specific single transcription start sites (TSS). In addition, a strong stimulation of 
RNA polymerase II (Pol II) dependent transcription initiation has been reported for these 
promoters by the synergistic interplay of the TATA box and INR core promoter elements. 
Recently, HMGA1 was identified as one of the factors required for the synergy between the 
TATA box and INR elements [45]. However, there is still need for further investigation to test 
the relevance of this finding as a general mechanism of transcription initiation. Gene 
transcription can also be regulated by the interplay of core promoter elements along with 
regulatory DNA elements, such as enhancers and silencers, which might be located several kilo 
base pairs (kbp) upstream or downstream of the promoter. In response to defined signals, specific 
proteins bind to the enhancer and form a complex called enhanceosome [78-81]. Looping of the 
DNA brings the enhaceosome and the core promoter in close proximity resulting in enhanced 
gene transcription. HMGA proteins are involved in enhanceosome formation [82, 83]. In 
addition, it has been reported that HMGA proteins have the ability to bend DNA [84]. Thus, a 
model can be suggested in which HMGA proteins participate not only in the formation of the 
enhanceosome but also in DNA looping and chromatin rearrangements that occur to bring 
enhanceosomes and core promoter in close proximity so that a coordinated assembly of the 
transcription initiation complex at core promoter can take place. It has been reported that the C-
terminal domain of HMGA proteins is required for the interaction of HMGA1 with TFIID [45]. 
This interaction seems to mediate core promoter specific functions since a C-terminal deletion 
mutant of HMGA1 fails to initiate transcription. This domain contains several conserved 
phosphorylation sites, for example SQ (Serine-Glutamine amino acid residues) sites, which are 
substrates for the kinases DNA-dependent protein kinase (DNA-PK), ATM and ataxia 
telangiectasia & Rad3-related protein (ATR). It has already been reported that ATM and ATR 
interact with and phosphorylate HMGA group proteins [85-87]. Hence they might be involved in 
fine-tuning the HMGA mediated cell specific gene transcription. 
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The second type of promoters, which contain CpG islands, lack TATA boxes and display 
multiple heterogeneous TSS. These promoters tend to be enriched with binding elements for 
SP1, NRF-1, E2F and ETS transcription factors [74, 88]. It was shown that HMGA1 interacts 
with SP1 and facilitates its binding to both the human insulin receptor gene promoter and the 
herpes simplex virus latency-active promoter 2 [89, 90]. This suggests that HMGA family 
members may also be involved in the transcriptional activation of CpG rich promoters. 
1.3.4	HMGA	and	Chromatin	
 
Chromatin constitutes the physiological template for all kinds of DNA-dependent processes as 
replication, recombination, repair and transcription. However, chromatin represents a strong 
barrier to sequence specific recognition sites on the DNA thereby increasing the complexity of 
DNA-dependent regulation processes. To overcome this barrier, it is a prerequisite to open the 
higher order chromatin structure so that regulators of the above mentioned processes can access 
their recognition sites on DNA and execute their function.  
There are several reports that HMGA proteins compete with H1 for binding to linker DNA 
thereby inducing a loosening of the chromatin structure (Figure 10B) [71, 91, 92]; However, the 
molecular mechanism underlying the replacement of histone H1 by HMGA proteins which 
results in chromatin opening is not well understood. Several post-translational modifications 
have been reported for Histone H1, such as phosphorylation, methylation, acetylation and poly-
ADP-ribosylation (PARylation) [93]. Similar to the core histones, these post-translational 
modifications of the linker histone H1 play a role chromatin structure regulation. PARP-1 
mediated PARylation of histone H1 leads to nucleosome-specific exchange of histone H1 by 
HMGB proteins inducing local changes of chromatin structure [94]. In a similar manner, histone 
H1 post-translational modifications could facilitate replacement of histone H1 by HMGA 
proteins thereby inducing chromatin decompaction. It is well known that the globular domain of 
histone H1 interacts and binds with linker DNA. Several motifs for kinases are located inside the 
globular domain or flank it. Phosphorylation of these sites might modulate the binding affinity of 
histone H1 to linker DNA [95] and might play a role during replacement of histone H1 by 
HMGA proteins.  
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Histone H1 eviction from chromatin is not enough to facilitate the access of regulatory elements 
on target genes because the DNA is still wrapped around the core histones hindering the 
accessibility of transcription factors to their binding elements. Hence, it further requires either 
eviction or mobilization of core histones. Several chromatin remodelers might be involved in 
these processes. For example, the facilitates chromatin transcription (FACT) complex has been 
reported to participate in H2A/H2B histone eviction/deposition [96], whereas anti-silencing 
factor 1 (ASF1) is involved in H3/H4 histone eviction/deposition [97]. HMGA proteins bind to 
both nucleosomes [44] and chromatin remodelers [98] suggesting co-ordination of these proteins 
in eviction and/or mobilization of core histones during transcriptional regulation (Figure 10). 
 
Figure 10. A model for the putative mechanism of HMGA 
proteins  as  factors  promoting  nucleosome  mobility  and 
accessibility  to  specific  DNA  sites  for  transcription 
activation.  (A) The nucleosome  is built of 146bp DNA  (red 
line)  surrounding  the  histone  octamer  (yellow  cylinder), 
which  consist  of  two  H2A‐H2B  dimers  and  one  (H3‐H4)2 
tetramer. The linker histone H1 (purple oval) binds to linker 
DNA outside the histone octamer at the position where the 
DNA  enters  and  exits  the  nucleosome  core  particle.  (B) 
HMGA  proteins  (green  oval)  can  compete  and  displace 
histone  H1  from  the  chromatin.  HMGA  binding  to  linker 
DNA in the chromatin and the subsequent displacement of 
histone H1  leads  to decompactness of  the  chromatin.  (C) 
The  relaxed  chromatin  structure acts as an anchoring  site 
for  the  recruitment  of  chromatin  remodeling  complexes 
(CRC, grey). Binding of this complex  is enhanced by HMGA 
proteins  and  induces  eviction  of  core  histones  and/or 
mobilization  of  complete  histone  octamers.  (E)  The 
chromatin remodeling events make sequence‐specific sites 
on  the  DNA  accessible  for  transcription  factor  (TF,  red 
pentagon  and  hexagon)  binding.  HMGA  proteins  might 
facilitate  the  formation  of  transcription  factor  complexes 
binding  to  these sequence‐specific sites. Later, Pol  II  (blue 
oval)  is  recruited  for  transcription  initiation  (black arrow). 
Adapted [32]. 
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1.4	ATM	and	H2AXS139ph	
 
ATM belongs to the superfamily of phosphatidylinositol 3-kinase-related kinases and 
phosphorylates SQ motifs. Mutations in the ATM gene cause a rare autosomal recessive 
neurodegenerative disorder named ataxia telangiectasia which involves a marked defect in 
responding to DNA double strand breaks (DSB) [99]. Histone variant H2AX, which represents 
about 2-25% of the cellular H2A pool in mammals, is well-known substrate of ATM. ATM 
phosphorylates H2AX on the serine 139 residue (also known as γ-H2AX). The H2AXS139ph is 
often used as a biomarker for DNA-DSB [100, 101]. However, there are accumulating evidences 
for additional functions related to this histone modification, such as neovascularization, Igk 
allelic exclusion, and ES cells self-renewal [102-104]. In addition, McManus et. al. analyzed the 
dynamics of H2AXS139ph in normally growing mammalian cells and found ATM-dependent 
H2AX phosphorylation in all phases of cell cycle with a peaking during M phase [105] thereby 
suggesting that H2AXS139ph may contribute to the fidelity of the mitotic process, even in the 
absence of DNA damage, thereby ensuring the correct transmission of genetic information from 
one generation to the next.    
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Chapter 2: AIMS 
 
In order to identify novel regulators of lung epithelial cell lineage during lung development, Dr. 
Guillermo Barreto screened a short interfering RNA (siRNA) library for pools that were able to 
reduce the basal transcription of a luciferase (Luc) reporter gene under the control of the 
surfactant protein C (Sftpc) promoter. Sftpc is the most specific marker of lung epithelial cell 
lineage [11]. Hmga2 was identified in this screening.  Its role during lung development and 
homeostasis was unknown. Thus, the aim of this thesis was to characterize the role of HMGA2 
as a novel regulator of lung development and further to elucidate its molecular mechanism.  
 
The specific aims of this study were: 
 
Aim 1: To determine spatiotemporal expression pattern of Hmga2 during mouse lung 
development. 
 
Aim 2: To assess the function of HMGA2 during mouse lung development by utilizing Hmga2-/- 
mice and siRNA based knock down of Hmga2 in mouse embryonic lung explant culture. 
 
Aim 3: To elucidate the molecular mechanism of HMGA2 mediated transcriptional gene 
regulation. 
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Chapter 3: MATERIALS & METHODS 
3.1	Molecular	Biology	Methods	
3.1.1	RNA	isolation	and	reverse	transcription	
For gene expression analysis, total RNA was isolated with RNeasy® plus mini kit (Qiagen) and 
quantified using NANODROP 2000 spectrophotometer (Thermo Scientific). The mouse tissue 
samples were collected; washed in ice-cold PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM 
Na2HPO4-2H2O, 1.4 mM KH2PO4) and snap frozen in liquid nitrogen. The homogenization of a 
tissue was conducted using Homogenizer (PEQLAB) in the presence of RLT buffer (Qiagen). 
After purification of RNA, purified RNA were reverse transcribed using the High Capacity 
cDNA Reverse Transcription kit (Applied Biosystem) to synthesise the DNA complementary to 
mRNA (cDNA) according to the manufacturer’s protocol. In brief, 2 μg RNA were mixed with 
0.8 μl 100 mM dNTP, 2 μl 10X random primers, 2 μl 10X reverse transcription buffer, 1 μl 
RNase inhibitor, 1 μl MultiScribeTM Reverse Transcriptase and upto 20 μl Nuclease free H2O. 
And then, following thermal cycle condition was used for cDNA synthesis.  
 
Step Temperature (0C)       Time (minute) 
1 25 10 
2 37 120 
3 85 5 
4 4 infinite 
 
3.1.2	Quantitative	PCR	
Quantitative polymerase chain reactions (qPCR) were performed using SYBR® Green on the 
Step One plus Real-time PCR system (Applied Biosystem).  
For quantitative reverse transcription PCR (RT-PCR), the qPCR results were normalized with 
respect to the housekeeping gene Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) and/or 
Alpha-tubulin (Tub1a1).    
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qPCR reactions were carried out in 20 μl  volume including:  
 
2x SYBR® Green buffer        5 μl 
10μM primer mix                  0.5 μl 
Template (DNA/cDNA)        1 μl 
H2O    up to 20 μl 
 
For the qPCR, following thermal cycle condition was used:  
 
Step Temperature (°C) Time (second)  
Initial denaturation      95           120  
Denaturation 94 30            
      40 cycles Extension 60 15 
Pause 4 infinite  
 
Primers used for PCR are listed in the Appendix Table1. 
The DNA sequences for all used genes are accessible via Ensembl database (http:// ensembl.org). 
For the designing and testing specificities of primers, Primer-BLAST 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) was utilized.  
Primer pairs were designed for gene expression analysis in a way that they are separated by at 
least one intron on the corresponding genomic DNA.   
3.1.3	Primer	efficiency	determination	
To determine efficiency of primers for qPCR, different dilutions (1:1, 1:2, 1:4, 1:8 & 1:16) of 
template (DNA or cDNA) were used. And following formula used to calculate primer efficiency 
from graph of CT values for each primer. 
Efficiency = 10 ((-1/slope) -1) X 100 
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3.1.4	Affymetrix	Microarrays		
For gene expression analysis, Affymetrix microarray-based transcriptome analysis of Hmga2-/- 
and Wild type (WT, Hmga2+/+) embryonic lung (E18.5) was performed and analyzed as 
described [106]. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment 
based analysis of deregulated pathways in Hmga2-/- vs. Hmga2+/+ was done using DAVID 
software [107] and generation of fold change and Heat map were performed using DNAStar 
Arraystar 11.0. The data discussed in this thesis have been deposited in NCBI's Gene Expression 
Omnibus [108] and are accessible through GEO Series accession number GSE55340 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE55340). 
3.1.5	Semiquantitative	PCR		
For genotyping the transgenic mice, cloning and Chromatin immunoprecipitation (ChIP) 
experiments semiquantitative PCR was used. For semiquantitative PCR, DNA templates were 
diluted to 1:10 and all reactions were carried out in 25 μl volume including:  
 
10X Taq Pol buffer              2.5 μl 
100 mM dNTP                     0.5 μl 
10 μM primer mix                1 μl 
DNA template                      1 μl 
Taq polymerase (Sigma)      1-2 units 
H2O     up to 25 μl   
 
For the semiquantitative PCR, following thermal cycle condition was used:  
 
Step     Temperature (°C) Time (second)  
Initial denaturing           95 120  
Denaturing   94 30  
              X cycles Annealing    56-60 30 
Extension         72 60 
Final extension              72 300  
Pause   4 infinite  
  
	 MATERIALS	AND	METHODS	
19
The amplified PCR products were mixed with gel loading dye (Fermentas) and then loaded on 
1% to 2% agarose gel for DNA band separation. 1X Tris/Borate/EDTA (TBE) electrophoresis 
buffer (1 l of 20X TBE: 1g NaOH, 216 g Tris Base, 110 g Boric acid, 14.8 g EDTA) was used to 
run agarose gel and ethidiumbromide (EtBr) was used to visualize DNA bands under UV light. 
The band size of the products was controlled by standard marker (100 bp or 1 kb GeneRulerTM 
DNA Ladder Mix, Fermentas).     
3.1.6	DNA	elution	from	agarose	gel	
Resolved DNA bands on agarose gel were purified using the QIAquick gel extraction kit 
(QIAGEN) according to the manufacturer’s instruction and eluted with 30 μl nuclease free H2O. 
3.1.7	Nucleic	acids	concentration	determination	
The DNA and RNA concentrations in solution were estimated using NANODROP 2000 
spectrophotometer (Thermo Scientific). The absorbance of the solution was measured at 260 nm 
and the concentration of nucleic acids was calculated by the manufacturer’s software based on 
Beer-Lambert Law (Aλ = εbc).  
Where, 
Aλ is the absorbance (Aλ = log10 P0 / P);  
ε is the molar absorbtivity (molar extinction coefficient);  
b is the path length of the sample;   
c is the concentration of the compound in solution.  
The molar absorbtivity for double stranded DNA is ε = 50 cm-1 M-1.  
The molar absorbtivity for single stranded DNA is ε = 33 cm-1 M-1.  
The molar absorbtivity for RNA is ε = 40 cm-1 M-1.  
3.1.8	Cloning		
The proximal 631bp Gata6 promoter was amplified and cloned into TOPO TA cloning vector 
(Invitrogen) and further subcloned into the pGL4 basic vector to generate pGL4-Gata6 promoter 
luciferase vector.  
Hmga2 cDNA fragment was subcloned from pcDNA3.1 Hmga2 WT (Addgene plasmid 14789) 
vector to pcDNA3.1(A)-myc\His (Invitrogen) to generate C-terminal myc\His tagged Hmga2 
mammalian overexpression vector.  
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To generate point mutation in constructs of H2AX-flag (S139 to D) and H1-flag/myc (S65 to A 
and D), QuickChangeTM Site-Directed Mutagenesis Kit (Stratagene) was used. 
Primers used for PCR were listed in the Appendix Table1. 
For cloning, ligation reaction was used as follows: 
 
Reagent Reaction volume (μl) 
2X Rapid ligation buffer               5 
Vector   1 
Insert      X 
T4 DNA ligase (3 Wiess U/μl)     1 
ddH2O   up to 10 
 
The ligation reaction mixture was mixed by pipetting, centrifuged briefly and incubated for 1 h at 
room temperature. Later, T4 DNA ligase in the ligation mix was heat inactivated for 20 minute at 
65°C, and used for bacterial transformation. 
A 1:3 (vector: insert) ratio was used for the ligation reaction. 
The Insert to Vector molar ratio was optimized using the following formula: 
X ng of Insert = [(ng of Vector x kb size of Insert) / kb size of Vector] x Insert: Vector molar 
ratio. 
3.1.9	Preparation	of	competent	E.coli	cells	
A single colony of E. coli strain (Top10 or XL1Blue) was inoculated in 5-6 ml Luria-Bertani 
(LB) medium and cultured overnight at 37°C on shaker with 200 RPM. 5 ml of grown culture 
was added into fresh 250 ml LB medium and grown to early logarithmic phase (OD 600 = 0.3 - 
0.6) at 37°C on shaker with 200 rpm. The culture was centrifuged for 10 min at 3000 rpm at 4°C 
in a table top centrifuge. The bacterial pellet was resuspended in 1/10th volume of cold TSB 
buffer [100 ml LB, 10 g PEG (MW = 3,350), 5 ml DMSO, 0.1 ml 1 M MgSO4, 0.1 ml 1M 
MgCl2] and incubated on ice for 10 min. Competent cell suspension was aliquoted into cold 
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eppendorf tubes (50 μl and 100 μl) and snap frozen in liquid nitrogen. Aliquoted snap frozen 
competent bacterial cells were stored at -80 °C.  
3.1.10	Transformation	of	E.	coli	competent	cells	
Ligation reaction mixture (4-8 μl) or plasmid DNA (1-20 ng) was added to the thawed competent 
cells and mixed by flicking. The reaction mixture was incubated on ice for 30 min followed by 
incubation at 42°C for 1.5 min and then kept on ice for 10 min. Later, 500 μl of LB medium 
(without any antibiotic) was added to the mixture and incubated for 1 hr at 37°C on shaker with 
200 rpm. And then, cells were spread plated on LB Agar plates containing appropriate antibiotic. 
Plates were incubated at 37°C overnight and next day colonies were observed.   
3.1.11	Plasmid	DNA	isolation	
The “mini-prep” method is useful for positive colonies screening i.e. to prepare plasmid DNA in 
small quantities from a number of transformants. A single colony was selected from LB agar 
plate and inoculated in 5 ml of LB medium containing the appropriate antibiotic with a sterile 
pipette tip. Bacterial cells were cultured overnight at 37°C on shaker with 200 rpm. The cells 
were harvested by centrifugation for 15 min at 4500 rpm in a table top centrifuge (Eppendorf 
5415C). Plasmid DNA was isolated using the Plasmid Miniprep kit (Sigma) following the 
manufacturer’s instructions. Large amount of plasmid DNA was prepared for downstream 
experiment using the Plasmid Midiprep Kit (Sigma) according to the manufacturer’s instructions. 
3.1.12	In	situ	hybridization	of	whole	mount	mouse	embryonic	lungs	
In situ hybridization is a method to visualize spatiotemporal presence of a specific RNA 
sequence in the entire tissue by labeled complementary RNA strands (probes). For this study, it 
was used to analyze the expression pattern of Hmga2 in murine embryonic tissues. For sample 
preparation, timed-pregnant C57BL6 wild type mice were sacrificed at indicated time points and 
embryos and embryonic lungs were isolated according to standard methods and whole mount 
mouse embryo and embryonic lung in situ hybridization was performed as described [109] with 
minor modifications. Briefly, to synthesize digoxigenin- labeled RNA probes, pcDNA3-
mHmga2 plasmid (a kind gift from Prof. Peter Grouse; [110]) template was linearized, and UTP-
digoxigenin (Roche) substituted antisense RNA probes were transcribed with T7 and sense RNA 
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probes were transcribed with SP6 RNA polymerase (as negative control). After in situ 
hybridization, embryonic lungs were post-fixed in 4 % PFA and imaged using Leica M205 FA.  
3.1.13	Chromatin	immunoprecipitation	
Chromatin immunoprecipitation (ChIP) analysis of the mouse Gata6 promoter was performed as 
described [111] with slight modifications. Briefly, MLE-12 cells were crosslinked by 1% 
formaldehyde for 10 minutes, neutralized with glycine for 5 min on ice, lysed and sonicated with 
Diagenode Biorupter to an average DNA length of 500-600 bp. After isolation, the soluble 
chromatin was immunoprecipitated with antibodies listed in the Appendix Table 2. ChIP-reChIP 
experiment was performed as previously described [112]. Reverse cross-linked 
immunoprecipitated chromatin was subjected to qPCR using the primers listed in the Appendix 
Table1.   
3.1.14	Luciferase	Reporter	Assay	
Dual-Luciferase reporter assays (Promega) were performed as described [113] following 
transient transfection of MLE-12 cells in 96-well plates with a total of 100 ng DNA per well, 
containing 15 ng effector plasmid, 15 ng pGL4-Sftpc promoter or SV40 promoter luciferase 
reporter plasmid, 1 ng Renilla luciferase reporter plasmid and 69 ng pBlueScript (pBS). Each 
sample was performed in triplicate and error bars indicate standard error of the mean. Each 
experiment was repeated at least three times. 
3.2	Cell	biological	methods	
3.2.1	Cell	culture	
MLE-12 and HEK293T cells were obtained from American Type Culture Collection (Manassas, 
VA). MLE-12 cells were cultured at 37°C in 5% CO2 in DMEM F12 with 5% fetal calf serum 
(FCS), 100 U\ml penicillin and 100 U\ml streptomycin. HEK293T cells were cultured at 37 0C in 
5% CO2 in DMEM with high glucose (4.5 g/l), 10% FCS, 2 mM L-Glutamine, 1 mM Pyruvate, 
100 U\ml penicillin and 100 U\ml streptomycin. Cellular growth and viability were assessed by 
phase contrast microscopy. The culture medium was replaced every other day. After attaining 
confluence, medium was aspirated from the cells, the cells were washed with 1X PBS and 
trypsinized with 1x trypsin-EDTA solution,diluted in 1x PBS. The trypsin-EDTA solution was 
neutralized with complete DMEM medium containing FCS. For experiment purposes, cells were 
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seeded at density 2x105/ml, which gave 70% confluence in 24 h. All the solutions added to cell 
cultures were prewarmed in a 37°C water bath. All manipulations were performed aseptically in 
a cell culture hood using sterile equipment.   
For the generation of FLAG-H2AX stable cell lines, HEK293T cells were co-transfected with a 
vector encoding for FLAG-H2AX wild type or S139A mutant (both gift of Dr. Kwon, [114]) and 
an empty pBABE vector, which provides the puromycin resistance. Cells at 80-90% confluence 
were transfected with Lipofectamine 2000 (Invitrogen) according to the manufacturer 
instructions. 48h after transfection the cells were split 1:4 and the next day 2.5 g/ml of 
puromycin were added to the media. Single positive clones were isolated and stably maintained 
in 1 g/ml of puromycin. Stable transfected HEK293T cells were cultured at 37 0C in 5% CO2 in 
DMEM with high glucose (4.5 g/l), 10% FCS, 2 mM L-Glutamine, 1 mM Pyruvate, 100 U\ml 
penicillin, 100 U\ml streptomycin and 1 μg/ml puromycin.   
3.2.2	Cryopreservation	and	thawing	of	cells	
Cultured cells were cryopreserved by resuspending the harvested pellet in freeze medium which 
contains 10% DMSO. The cells were transferred to a cryogenic vial and immediately placed in a 
-80°C freezer overnight before transfer to -195°C liquid nitrogen for long term storage. To thaw, 
cell vials removed from liquid nitrogen and were thawed rapidly in a 37°C water bath and cells 
were immediately rinsed once in growth medium to remove the freeze medium and then 
cultured. 
	3.2.3	Transient	transfection	
Cells were transiently transfected using lipofectamine 2000 reagent (Invitrogen), a 1:1 (w/w) 
liposome formulation of the cationic lipid N-[1-(2,3-dioleyloxy)propyl] 
n,n,ntrimethylammonium chloride (DOTMA) and dioleoyl phosphotidylethanolamine (DOPE) in 
membrane filtered water. 
Cells were maintained as described (Section 3.2.1). 70-80% confluent cells were used for the 
transfection experiments. On the day of transfection, plasmid DNA or siRNA was diluted in Opti 
MEM medium (Gibco). Separately, Lipofectamine 2000 reagent (Invitrogen) was diluted in Opti 
MEM medium. DNA: Lipofectamine was used in the ratio of 1:2.The diluted plasmid DNA/ 
siRNA and the diluted lipofectamine 2000 reagent were pre-incubated at room temperature for 5 
min before being mixed to make complexes. Complexes were allowed to form for a further 15 
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min at room temperature and then, added onto the cells. After 6 hrs, this medium was replaced 
with complete DMEM medium. Cells were analyzed after a given time point. Transfection 
volumes were scaled up or down according to the surface area of the tissue culture vessel in use 
(Lipofectamine 2000 reagent, Invitrogen, data sheet). 
3.2.4	Transient	transfection	efficiency	assessment	
For overexpression studies, transfection efficiency was monitored after transiently transfecting 
cells with GFP (Green fluorescence protein) over expressing construct and later after 48 hrs 
assessing the percentage of GFP positive cells under fluorescent microscope (Leica). For siRNA-
mediated inhibitory studies, transfection efficiency was monitored after transiently transfecting 
the cells with Cy3 labeled siRNA (AM4621, Applied biosystem) and later after 48 hrs assessing 
the percentage of Cy3 positive cells under fluorescent microscope (Leica).  
siRNA used in the study are 40 nM siCtrl (Negative control, AM4611; Ambion), 40 nM siGata6 
(L-065585-00; Dharmacon), 20 nM siFzd2 (s81164; Applied Biosystem), 20 nM siHmga2 
(s67600, Applied Biosystems), 20 nM siRNA control (siCtrl; D-001210-01-05; Dharmacon), 20 
nM siATM (SIHK0133; Sigma) and 20 nM siHMGA2 (M-013495-02; Dharmacon). 
3.2.5	Cell	treatment	
HEK293T cells were treated with 10 μM ATM kinase inhibitor KU-55933 (Merk Chemicals 
Ltd.; Cat. No.: 118500). DMSO used as solvent for ATM kinase inhibitor KU-55933. Cells were 
harvested after 48 h for further analysis.   
3.2.6	Lung	explants	culture	methods		
Timed-pregnant [C57BL6 wild type or beta-catenin/TCF/LEF reporter transgenic (BAT-GAL)] 
mice were sacrificed on post coitum day 12.5 (E12.5, day of plug = E0.5) according to standard 
methods. BAT-GAL transgenic mice were genotyped by ß-galactosidase staining and PCR (a 
gift of Stefan Liebner [115]). Lungs were dissected from the embryos and cultured for 72 hours 
equivalent to E15.5 (E15.5*) as previously described [116]. The lungs were treated with 3 µM 
siRNAs against Hmga2 (Applied Biosystems, Silencer Select siRNAs, Assay ID s67600), Gata6 
(L-065585-00; Dharmacon) and Scrambled siRNA (negative control, Ctrl) (Sigma, MISSION 
siRNA Universal Negative Control, SIC001) or 200 nM of mouse recombinant Dickkopf-1 
(DKK1, R&D Systems, 5897-DK-010). The siRNA and protein treatments were renewed every 
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24 h. After 72 h, the lungs were checked for morphological changes by standard microscopy 
techniques and harvested for RNA (QIAGEN Rneasy Micro Kit) and protein isolation. 
Transfection efficiency was monitored after transiently transfecting the lung explants at E12.5 
with Cy3 labeled siRNA (AM4621, Applied Biosystem) and later, after 72 hrs assessing the 
percentage of Cy3 positive cells under fluorescent microscope (Leica). The images were used to 
determine the total number of terminal bud branches and for quantification of total branch length 
as described [117].  
3.3	Animal	experiments	
3.3.1	Mice	
C57BL/6 and Hmga2+/- mice (stock # 002644, Jackson Laboratories;[118]) were obtained from 
Charles River Laboratories, Germany at 5 to 6 week of age. Hmga2 overexpression mice were 
kind gift from Prof. Monica Bessler [119]. Animals were housed and bred under controlled 
temperature and lighting [12/12-hour light/dark cycle], fed with commercial animal feed and 
water ad libitum. All experiments were performed with 6-8 week old mice according to the 
institutional guidelines that comply with national and international regulations.  
Wild type, beta-catenin+/- (CMV-Cre-,Ctnnb1tm2Kem, [120]) and Doxycycline-inducible Dkk1 
(Rosa26rtTA, Tet (0) Dkk1; [121]) mice were administered orotracheally control 
[PLKO.shControl] or Hmga2 [PLKO.sh Hmga2] plasmids. Hmga2-/- mice were administered 
orotracheally control [empty vector] or Gata6 expression vector [pCMV6-entry-Gata6-flag/myc 
(origene)]. The plasmids were prepared in PEI transfection reagent (Sigma-Aldrich) at 50 µg/Kg 
dose, and administered three times (days -10; -7 and -3). Doxycycline-inducible Dkk1 mice were 
treated with doxycycline (0.4 mg/ml in water) starting at -7 day. The lungs were harvested (day 
0) and used for RNA isolation, FACS analysis and immunohistochemistry. The pLKO.1-puro 
shDNA constructs were obtained from the Sigma MISSION shRNA library/TRC [122].   
3.3.2	Compliance	Measurement	
Anesthetized and relaxed Wild type and Hmga2 -/- mice were tracheotomized, placed in a small 
animal whole-body plethysmographic chamber (Buxco), and ventilated in volume-driven mode 
(with a positive end-expiratory pressure [PEEP] of 300 mmHg) as described [123]. Before 
measurement of lung compliance, chambers were calibrated with a rapid injection of 300 μl 
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room air. Respiration rate was set to 20/min, and ventilation pressure was recorded while 
inflating the lung at a tidal volume of 200 μl. Ventilator compliances are given in kPa/ml and 
corrected for mouse whole-body weight. 
After compliance measurement, thorax was opened and lung was then perfused with 1X PBS. 
The lung was either frozen for protein and mRNA isolation or perfusion-fixed with 4% 
paraformaldehyde for 15 min with a pressure of 20 cm H2O for histology. 
3.4	Histology	and	Immunohistochemistry	
3.4.1	H&E	staining	
Hematoxylin & Eosin (H&E) staining was done for morphometric analyses. Mouse embryonic 
lung and adult lung were fixed in 4% PFA/PBS at 4°C overnight. Fixed embryos were 
dehydrated by incubating them in series of ethanol:water mixtures (50:50, 70:30, 80:20, 90:10, 
96:04) and twice with 100% ethanol for mouse 2 h each step at room temperature. Dehydrated 
lungs were washed with butanol overnight at RT and then twice with paraffin (at least 2-3 h each 
step at 65°C). Washed lungs were embedded in parraffin and sectioned with a microtome (4 μm 
thick) and mounted on glass slides after stretching them by putting them in a 42°C water bath. 
After mounting, glass slides were incubated at 42°C overnight and stored at RT for further 
experiments. Mounted sections were deparaffinised by washing thrice with xylol (10 min each 
step), twice with 100% ethanol (5 min each step) and then series of ethanol: water mixtures 
(96:4, 90:10, 70:30, 50:50) for 5 min each step. At last sections were washed with tap water at 
least for 5 min. For staining rehydrated mounted sections were incubated in Hemalum for 10 min 
and washed with warm running tap water until sections became blue. Sections were rinsed with 
distilled water for 1-2 min. After Hemalum staining sections were incubated with eosin solution 
for 6 min and shortly washed once with 95% ethanol and once with 100% ethanol. At last 
sections were put into xylol and mounted with xylol-based mounting medium (Entellan, Merck). 
Mounted samples were analyzed by bright field microscopy.  
3.4.2	Immunostaining	
For cryosections of mouse lung tissue, lungs were harvested and embedded in polyfreeze tissue 
freezing medium (Polysciences, Inc.). Sections of 10 µm were cut on a cryostat (Leica 
Germany). Sections were post-fixed in 4% PFA for 10 min. Antibody staining was performed 
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following standard procedures. All incubations and washes were done with histobuffer 
containing 3% BSA and 0.2% Triton X-100 in 1× PBS, pH 7.4. Unspecific binding sites were 
blocked over 45-60 minutes with donkey serum and histobuffer (1:1 (v/v) ratio). The sections 
were then incubated with primary and secondary antibodies for 60 min followed by nuclear 
staining. The sections were examined with a Zeiss confocal microscope (Zeiss, Germany).  
For Paraffin embedded mouse lung tissue, Lungs were post-fixed overnight in 1% PFA at 
4°C, dehydrated over a graded series of alcohol, and paraffin embedded. Sections of 4 µm were 
cut on a microtome (Leica Germany). Antigen retrieval was performed by microwave heating for 
8 min using 1mM EDTA. Antibody staining was performed following standard procedures. All 
incubations and washes were done with histobuffer containing 3 % BSA and 0.2 % Triton X-100 
in 1× PBS, pH 7.4. Unspecific binding sites were blocked over 45-60 minutes with donkey 
serum and histobuffer (1:1 (v/v) ratio). The sections were then incubated with primary and 
secondary antibodies for 60 min followed by nuclear staining. The sections were examined with 
a Zeiss confocal microscope (Zeiss, Germany). 
Primary and secondary antibodies used were listed in Appendix Table 2. DAPI (Invitrogen) or 
DRAQ5 (eBioscience) was used as nuclear dye.   
Paraformaldehyde fixed and paraffin embedded lung tissue sections were further used for H & E 
staining using standard method for the lung morphology and morphometric analysis. Leica 
DM6000B microscope with an automated stage and Leica QWIN V3 digital image processing 
and analysis software were used for the lung morphometric analysis. 
3.4.4	β‐Gal	staining	
BAT-GAL transgenic mice embryonic lung explants were fixed at room temperature for 15 min 
in solution A (0.4 ml 25% Gluteraldehyde, 0.5 ml 0.5M EDTA, 0.2 ml 0.5M MgCl2 to 50 ml 
with 1X PBS). After fixation washed three times for 10 min in solution B (0.8 ml 0.5 M MgCl2, 
2 ml 2% NP-40, 2 ml 10% Na-deoxycholate to 200 ml with 1X PBS). After washing lung 
explants were stained at 37 0C in solution C (100 ul K-hexacyanoferrate (II) [Ferroso], 100 ul K-
hexacyanoferrate (III) [Ferrico], 200 ul 50 ug/ml X-gal and 9.6 ml solution B). Once color is 
developed then washed 3 times for 10 min each in solution B and once in PBS and image were 
taken using inverted light microscope. 
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3.4.5	Flow	Cytometry	
Flow cytometry analysis was performed as described [31] using mouse adult lungs. Single cell 
suspension from lung was obtained as described earlier [6]. Cells were analysed for SFTPC- and 
SCGB1A1-staining using BD LSRII flow cytometry. Data were analysed with Weasel software. 
3.5	Biochemical	methods	
3.5.1	In	vitro	chromatin	reconstitution	and	Histone	eviction	assays	
An 806 bp 5’-biotin labeled PCR amplicon carrying the mouse Gata6 promoter was immobilized 
on streptavidin-coated magnetic Dynabeads following supplier’s instruction (Invitrogen). 
Immobilized Gata6 promoter and recombinant histones (NEB; H3.3, M2507S; H2B, M2505S; 
H2A, M2502S; H4, M2504) and/or H4-his tag (KeraFAST, FS0004) or H2A-his tag (BPS 
BioScience, 52025) were used for in vitro chromatin reconstitution by salt dialysis method [124] 
using a molar ratio of 1:0.6 (w:w) of DNA : histone octamer. The optimal molar ratio of histone 
octamer: DNA was titrated in a series of reactions, in which different molar input ratios were 
tested and analyzed. Quality of reconstituted chromatin was analyzed using 0.1 unit Micrococcal 
nuclease as previously described [125]. Proximal 631 bp mice Gata6 promoter was cloned into 
TOPO TA cloning vector (Invitrogen) and used as template. T7 primer along with 5’-biotin 
labeled SP6 primer was used for 806 bp long 5’-biotin labeled amplicon synthesis by PCR.  
In vitro reconstituted chromatin was incubated with 40 g HEK293T nuclear protein lysates for 
15 min at room temperature. After incubation with nuclear protein lysates, supernatant was 
removed and the immobilized chromatin was washed once followed by Hind III (NEB) digestion 
to separate the in vitro reconstituted chromatin from magnetic beads. Later, the supernatant and 
separated chromatin from beads was used for western blot analysis. 
3.5.2	Affinity‐precipitation	and	Immunoprecipitation	
Total of 5 x 107 of each MLE-12 cells and Hmga2 over expressed MLE-12 cells were collected 
and washed three times in cold PBS, spun down at 1100 rpm for 10 min at 4 0C. Cells were 
incubated in 2 ml of hypotonic cell lysis buffer (10 mM (pH7.4) Tris-HCl, 1.5 mM MgCl2, 10 
mM KCl, 1 mM DTT, 25 mM NaF, 0.5 mM Na3VO4, 40 μg/ml phenylmethylsulfonyl fluoride 
(PMSF) and protease inhibitor (Calbiochem)) on ice for 10 min and then spun down at 3500 rpm 
for 10 min at 40C. Nuclear cell pellets were resuspended in 300 µl Nuclear lysis buffer (50 mM 
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(pH 7.4) Tris-HCl, 170 mM NaCl, 20% glycerol, 15 mM EDTA, 0.1% (v/v) Triton X-100, 0.2 
mM DTT, 20 mM NaF, 0.5 mM Na3VO4, 40 μg/ml PMSF and protease inhibitor). Nuclear 
protein lysates were incubated overnight rolling at 40C with 60 µl Ni+ sepharose beads (GE 
Healthcare) which were preincubated with lysis buffer containing 1% BSA. An amount of 5% 
nuclear lysate was kept as Input control. Beads were collected at 2500 rpm for 3 min at room 
temperature and washed with 500 µl washing buffer (50 mM (pH 7.4) Tris-HCl, 170 mM NaCl, 
15 mM EDTA, 0.4% (v/v) Triton X-100, 20 mM Imidazole, 20 mM NaF, 0.5 mM Na3VO4, 40 
μg/ml PMSF and protease inhibitor) 5 times. Elution was performed in 60 ul of elution buffer 
(50 mM (pH 7.4) Tris-HCl, 500 mM NaCl, 15 mM EDTA, 0.4% (v/v) Triton X-100, 500 mM 
Imidazole, 20 mM NaF, 0.5 mM Na3VO4, 40 μg/ml PMSF and protease inhibitor). The eluates 
were subjected to mass spectrometry analysis.      
Co-IPs were performed as described [86] with minor adaptations. Briefly, nuclear protein lysates 
were prepared as described above. Precleared 500 µg nuclear protein lysates were incubated with 
the 0.5 to 1 µg antibodies on ice for 2 h and then 30 µl protein-G-sepharose beads (GE 
Healthcare; equilibrated once in 10 ml water and three times in washing buffer) were added and 
incubated overnight at 4 0 C rolling. Beads were collected and washed 5 times with 500 µl ice 
cold washing buffer. 30µl 2x SDS sample loading buffer was added to beads, boiled at 95 0C for 
5min, spun down and loaded on SDS-PAGE.    
Immunoprecipitation to analyze ATM kinase activity was performed as previously described [85, 
86] using an antibody specific against phospho-(Ser/Thr) ATM substrate (Cell Signaling). 
3.5.3	 Mass	 spectrometry:	 sample	 preparation,	 methods	 and	 data	
analysis	
Mass spectrometry identifies proteins by ionization of chemical compounds to charge peptides 
and measurement of their mass to charge ratio. This technique was utilized for proteomic based 
HMGA2 interactome analysis. Therefore, cell nuclear lysates from control and Hmga2-myc/his 
over-expressed MLE-12 cells were used for affinity-precipitation (Histidine-pulldown) and later 
were run on NuPAGE 4-12% BIS-TRIS gel (Invitrogen, Carlsbad, USA). Gels were stained with 
colloidal blue (Invitrogen), and evenly sized gel pieces were excised and processed for mass 
spectrometry. The gel pieces were subjected to in-gel reduction and alkylation, followed by 
trypsin digestion as described previously [126]. 
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Reverse phase nano-LC-MS/MS was done by using an Agilent 1200 nanoflow LC system 
(Agilent Technologies, Santa Clara, CA) with a cooled thermostated 96-well autosampler. The 
LC system was coupled to LTQ-Orbitrap instrument (Thermo Fisher Scientific) equipped with a 
nanoeletrospray source (Proxeon, Denmark). Chromatographic separation of peptides was 
performed in a 10 cm long and 75 µm inner diameter capillary needle. The column was custom-
made with methanol slurry of reverse-phase ReproSil-Pur C18-AQ 3 µm resin (Dr. Maisch 
GmbH). The tryptic peptide mixtures were autosampled at a flow rate of 0.5 µl/min and then 
eluted with a linear gradient at a flow rate 0.25 µl/min. The mass spectrometers were operated in 
the data-dependent mode to automatically measure MS and MS/MS spectra. LTQ-FT full scan 
MS spectra (from m/z 350 to 1750) were acquired with a resolution of r = 60,000 at m/z 400. 
The five most intense ions were sequentially isolated and fragmented in the linear ion trap by 
using collision-induced dissociation with collision energy of 35%. Further mass spectrometric 
parameters: spray voltage of 2.4 kV, no sheath gas flow, and the temperature of the heated 
capillary was 200 °C.  
For data analysis we used the MaxQuant software tool (Version 1.2.0.8). The measured raw data 
were processed and quantitated as described [127]. 
3.5.6	Western	blot	
Western blotting used standard methods. Antibodies used were listed in Appendix Table 2. 
Immunoreactive proteins were visualized with the corresponding HRP-conjugated secondary 
antibodies using the Super Signal West Femto detection solutions (Thermo Scientific). Signals 
were detected and analyzed with Luminescent Image Analyzer (Las 4000, Fujifilm). Protein 
concentrations were determined using BCA kit (Sigma). 
3.6	Statistical	analysis	
Statistical analyses were performed using Excel Solver. All data are represented as mean ± 
Standard Error (mean ± s.e.m). One-way analyses of variance (ANOVA) were used to determine 
the levels of difference between the groups and P values for significance. P values after one-way 
ANOVA,* P ≤ 0.05; ** P < 0.01 and *** P < 0.001 Only in Figures 17C-D unpaired t-test was 
used to calculate P values, *** P<0.001; ** P<0.01; * P<0.05.  
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Chapter 4: RESULTS 
4.1	 Hmga2	 is	 required	 for	 proper	 distal	 epithelial	 cell	
differentiation	during	lung	development	and	homeostasis		
4.1.1	 Hmga2	 is	 expressed	 in	 the	mouse	 embryonic	 lung	 at	 the	 distal	
airways	
To verify that Hmga2 is expressed during lung development, qRT-PCR based gene expression 
analysis was performed (Figure 11A). Hmga2 transcript was detected at E11.5, when the primary 
lung buds have evaginated from the foregut and secondary buds are forming as outgrowths from 
the primary lung buds. During the pseudoglandular stage of lung development (E12.5 – E16.5), 
Hmga2 expression progressively decreased. Between canalicular (E16.5 – E17.5) and initial 
saccular stages (E17.5 – E18.5), the levels of Hmga2 transcript increased again. Later in 
gestation (saccular stages, E18.5 – P5), Hmga2 expression was further reduced and reached a 
basal level of expression that was maintained through alveolar phase (P5 – P28). Thus, Hmga2 
mRNA levels were high during early stages of lung development, in which cells are 
undifferentiated, and decreased as lung development progressed, coincident with cell 
differentiation. 
In situ hybridization expression pattern analysis in the embryonic lung at E12.5 (Figure 11B), 
revealed that Hmga2 is ubiquitously expressed with higher levels of expression at the tips of the 
growing lung buds. Interestingly, Hmga2 expression became restricted to the distal lung 
endoderm at E14.5. Consistently, immunostaining on sections of the embryonic lung at E14.5 
(Figure 11C) supported the presence of HMGA2 in cells of the distal lung endoderm. Co-
staining with an antibody specific for the nuclear envelope protein LMNB1 demonstrated the 
nuclear localization of HMGA2 (Figure 11C). The observed expression patterns in embryonic 
lung suggest a role for HMGA2 in epithelial differentiation.  
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Figure  11.  Hmga2  is  expressed  in  the  mouse  embryonic  lung  at  the  distal  airways.  (A)  Hmga2  and  Gapdh 
expression was analyzed by qRT‐PCR  in mouse embryonic  lung at different days post coitum (E11.5‐E18.5) and  in 
mouse  lung at different days after birth  (P1‐P28). Rel nor exp,  relative expression normalized  to Tuba1a. Error 
bars,  s.e.m.  (n=4).  (B)  Hmga2  mRNA  was  detected  in  mouse  embryonic  lung  at  E12.5  and  E14.5  by  in  situ 
hybridization using an Hmga2‐specific antisense RNA probe. Sense probe, negative control. Scale bars, 200 m. 
Square shows details at higher magnification. (C) Fluorescence microscopy of embryonic lung sections (E14.5) after 
double immunostaining using HMGA2‐ and LMNB1‐specific antibodies. Nuclear staining with DAPI (blue). Squares 
as in B. LMNB1, LAMIN B1. Scale bars, 40 m.   
 
4.1.2	 Hmga2	 is	 required	 for	 proper	 differentiation	 of	 the	 distal	
epithelium	during	lung	development	
 
To determine the role of Hmga2 during lung development, embryonic lung of Hmga2-/- mice 
[118] was analyzed at E18.5. Hmga2-/- mice embryos showed reduced body weight (Figure 12A) 
and lung-to-body-wet-weight ratio (Figure 12B). Hmga1, another member of HMGA group 
protein family member expression was analyzed in Hmga2-/- mice embryos by qRT-PCR (Figure 
12C).  Hmga2-/- mice embryos showed no change in Hmga1 expression when compared to the 
wild type mice.  
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Figure 12. Hmga2‐/‐ mice showed embryonic lung defect.  (A) Top, Hmga2‐/‐ mouse embryos at E18.5 were smaller 
than WT embryos. Main  interval of the scale  is equivalent to 1 cm. Bottom, Hmga2‐/‐ embryo showed 40% body 
wet weight reduction when compared to WT embryos. Data are represented as mean ± s.e.m. (n=3). Asterisks, P 
values after one‐way ANOVA, *** P < 0.001; ** P < 0.01; * P < 0.05. (B) Lungs of Hmga2‐/‐ embryo were smaller 
(top) and  showed a  reduced  lung‐to‐body‐wet‐weight  ratio  (bottom) when  compared  to WT embryos at E18.5. 
Scale bars, 1 mm. Error bars, s.e.m. (n=6). Asterisks as in A. (C) Expression analysis of the indicated genes by qRT‐
PCR  in  embryonic  lung  (E18.5)  of  WT  and  Hmga2‐/‐  mice.  Error  bars,  s.e.m.  (n=4).  Asterisks  as  in  A.  (D) 
Representative of histological analysis using H&E staining on sections of WT and Hmga2‐/‐ embryonic lung at E18.5. 
Squares as in Fig. 11B. Scale bars, 100 m. (E) Sections of embryonic lung (E18.5) of WT and Hmga2‐/‐  mice were 
analyzed by confocal microscopy after double  immunostaining using KRT‐ and VIM‐specific antibodies. KRT, Pan 
Cytokeratin and VIM, Vimentin. Scale bars, 40 m.  (F) Quantification of epithelial  (KRT) and mesenchymal  (VIM) 
cells of Hmga2‐/‐ and WT embryonic  lung  immunostained as  in E. Error bars,  s.e.m.  (n=3). Asterisks as  in A.  (G) 
Expression  analysis  of  the  indicated  genes  by  qRT‐PCR  at  E18.5  of  WT  and  Hmga2‐/‐  mice  lung.  Scgb1a1, 
Secretoglobin 1A1. Error bars,  s.e.m.  (n=4). Asterisks as  in A.  (H) Sections of embryonic  lung  (E18.5) of WT and 
Hmga2‐/‐ mice were analyzed by confocal microscopy after  immunostaining using SFTPC‐ specific antibody. Scale 
bars, 40 m.     
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Histological analysis of the embryonic lung at this stage (Figure 12D) revealed a marked 
increase of cell density in the Hmga2−/− mice when compared to the WT mice suggesting 
increased cell proliferation. Furthermore, immunostaining on sections of embryonic lung (Figure 
12E) using antibodies specific for the epithelial marker KRT (pan-cytokeratin) and the 
mesenchymal marker VIM (vimentin) showed an increase in the mesenchymal cells and an 
irregularly shaped epithelium in Hmga2−/− mouse lungs when compared to the WT lung, 
suggesting an expansion of the mesenchyme at the expense of the epithelium. Consistent with 
this observation, quantification of KRT-positive cells (Figure 12F, top) showed a decrease from 
61.7% to 29.5% (P < 0.001; n = 3), whereas the number of VIM-positive cells (Figure 12F, 
bottom) increased from 35.7% to 46.3% ((P < 0.001; n = 3) in Hmga2−/− mice when compared to 
the WT mice. Thus, to examine lung epithelium differentiation, expression of proximal, 
Scgb1a1, and distal, Sftpc, epithelial markers was analyzed in the embryonic lung of WT and 
Hmga2−/− mice (Figure 12G). Whereas Scgb1a1 expression did not change significantly, Sftpc 
expression was reduced after Hmga2−/−, suggesting defects in distal epithelium differentiation. 
These defects were confirmed by immunostaning on sections of embryonic lung (Figure 12H) 
that showed reduced levels of SFTPC after Hmga2−/− when compared to the WT mice. 
Furthermore, co-localization of HMGA2 and SFTPC in the same cells of the embryonic lung at 
E14.5 (Figure 13A) supported Hmga2 direct involvement in distal lung epithelial differentiation. 
 
 
 
 
 
 
 
Figure 13. HMGA2 and SFTPC co‐localized  in the same 
cells of the embryonic lung. Fluorescence microscopy of 
embryonic  lung  section  (E14.5)  after  double 
immunostaining  using  HMGA2‐  and  SFTPC‐specific 
antibodies. Squares as in Fig. 11B.  
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To further investigate the effect of Hmga2−/− on cell proliferation in embryonic lung, 
immunostaining on sections of embryonic lung was performed using cell proliferation markers 
PCNA (proliferating cell nuclear antigen) and MKI67 (antigen identified by monoclonal 
antibody Ki 67) (Figure 14A, B) which showed increased levels of proliferation markers in both 
the epithelium and the mensenchyme of the Hmga2−/− mice as shown by co-staining with 
antibodies specific for CDH1 or KRT or VIM supporting interpretation of the histological 
analysis. However, quantification of these results (Figure 14C) showed more prominent cell 
proliferation in the mesenchyme (right), from 3.9% to 43.3% (P < 0.001; n = 3), when compared 
to the epithelium (left), from 8% to 23.6% (P < 0.001; n = 3). To confirm increased cell 
proliferation in the embryonic lung after Hmga2−/−, expression of cell cycle progression markers 
Ccne1, Ccne2 and Ccnd2 (Cyclin E1, E2 and D2; Figure 14D) was analyzed. Enhanced 
expression of these genes in Hmga2−/− embryonic lung when compared to WT lung supported 
the observation of the elevated cell proliferation.   
Further, co-staining with distal epithelial cell marker SFTPC and cell proliferation marker PCNA 
on sections of embryonic lung (Figure 15A, left) was performed which showed that reduced 
numbers of SFTPC-positive cells from 10.8% to 2.7% (P < 0.001; n = 3) in Hmga2−/− when 
compared to the WT mice, while no change was observed in the proliferation of the SFTPC 
positive cells (Figure 15B, left). Thus, to check distal epithelial progenitor cell population, 
immunostaining on sections of embryonic lung was performed using antibodies specific for the 
distal epithelial progenitor cell marker SOX9 (sex determining region Y-box 9) and PCNA 
(Figure 15A, right). The number of SOX9-positive cells increased from 3.8% to 35.3% (P < 
0.001; n = 3) in Hmga2−/− when compared to WT mice (Figure 15B, right). Interestingly, most 
of the SOX9-positive cells in the Hmga2−/− lung were proliferating as shown by PCNA co-
staining supporting the distal epithelial progenitor cell differentiation defect in Hmga2−/− 
embryonic lung when compared to WT lung.     
In addition to cell proliferation, programmed cell death is an important process involved in lung 
development [128]. Thus, co-staining on sections of embryonic lung (Figure 16A,B) was 
performed using antibodies specific for the active form of the apoptosis-related cysteine 
peptidase, cleaved caspase 3 (clCASP3) and the epithelial marker KRT ( Figure 16A, left) or the 
mesenchymal marker ACTA2 (smooth muscle actin alpha 2, Figure 16A, right). Quantification 
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of clCASP3-positive cells showed that while the level of apoptosis in the mesenchyme (Figure 
16B, right) was not significantly affected in Hmga2−/− (0.2% in the WT versus 0.3% in the KO), 
it increased in the lung epithelium (Figure 16B, left) of Hmga2−/− mice from 2.7% to 7.5% (P < 
0.01; n = 3) supporting the reduction of epithelium when compared to WT mice.   
 
 
Figure  14. Hmga2‐/‐  mice 
embryonic  lung  showed  increased 
cell  proliferation.    (A)  Sections  of 
embryonic lung (E18.5) of Hmga2‐/‐ 
mice  were  analyzed  by  confocal 
microscopy  after  double 
immunostaining using (left) MKI67‐ 
and  CDH1‐specific  antibodies  or 
(right)  PCNA‐  and  VIM‐specific 
antibodies. CDH1, E‐cadherin. Scale 
bars,  40  m.  (B)  Sections  of 
embryonic lung (E18.5) of Hmga2−/−  
mice  were  analyzed  as  in  A  using 
(left)  KRT‐  and  PCNA‐specific 
antibodies  or  (right)  VIM‐  and 
MKI67‐specific  antibodies.  Scale 
bars,  40  m.  (C)  Quantification  of 
proliferating  (PCNA  or  MKI67 
positive)  epithelial  (KRT)  and 
mesenchymal  (VIM)  cells  at  E18.5 
of  WT  and  Hmga2−/−  mice  lung 
immunostained as  in B. Error bars, 
s.e.m. (n=3). (D) Expression analysis 
of  the  indicated  cell  proliferation 
marker genes by qRT‐PCR  in E18.5 
lung  of  WT  and  Hmga2−/−  mice. 
Error bars, s.e.m. (n=3). Asterisks as 
in Fig. 12A.   
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Figure  15.  Hmga2‐/‐  mice  embryonic  lung  showed  increased  cell  proliferation  in  the  distal  lung  epithelial 
progenitor cells.  (A) Sections of embryonic  lung  (E18.5) of Hmga2‐/‐ mice were analyzed by confocal microscopy 
after double immunostaining using SFTPC‐ and PCNA‐specific antibodies (Left) and using SOX9‐ and PCNA‐specific 
antibodies  (Right). Scale bars, 40 m.  (B) Sections of embryonic  lung  (E18.5) of Hmga2‐/‐ mice were analyzed by 
confocal microscopy after double immunostaining as in A and quantified. Error bars, s.e.m. (n=3).    
 
Figure 16. Hmga2‐/‐ mice embryonic  lung showed  increased cell apoptosis  in the distal  lung epithelial cells. (A) 
Sections  of  embryonic  lung  (E18.5)  of  Hmga2‐/‐  mice  were  analyzed  by  confocal  microscopy  after  double 
immunostaining  using  KRT‐  and  clCASP3‐specific  antibodies  (Left)  and  using  ACTA2‐  and  clCASP3‐specific 
antibodies (Right). Scale bars, 40 m. (B) Sections of embryonic lung at E18.5 of Hmga2‐/‐ mice were analyzed by 
confocal microscopy after double immunostaining as in A and quantified. Error bars, s.e.m. (n=3).    
 
4.1.3	 Hmga2	 knockout	 compromised	 adult	 lung	 function	 due	 to	
epithelial	cell	differentiation	defect	
 
 Adult lung of Hmga2-/- mice was analyzed to confirm the phenotype of embryonic lung. 
Hmga2−/− adult lung also showed a reduced lung-to-body-wet-weight ratio (Figure 17A). H&E 
staining of Hmga2−/− adult lung section showed marked impairment in cellular structure (Figure 
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17B). Consequently, Hmga2−/− affected both lung morphology, as shown by increased septal 
wall thickness and reduced air space (Figure 17C), as well as lung function, as shown by 
increased airway resistance and reduced compliance (Figure 17D).      
 
 
Figure 17. Hmga2‐/‐  showed  compromised adult  lung  function due  to epithelial  cell differentiation defect.  (A) 
Lungs of Hmga2‐/‐ mice were smaller  (top) and showed a reduced  lung‐to‐body‐wet‐weight ratio  (bottom) when 
compared to WT. Main interval of the scale is equivalent to 1 cm. Error bars, s.e.m. (n=3). Asterisks as in Fig. 12A. 
(B) Histological analysis using H&E  staining on  sections of WT and Hmga2‐/‐ adult  lung. Scale bars, 100 m.  (C) 
Hmga2‐/‐  increased  septal wall  thickness and  reduced air  space  in adult  lung. Sections of adult  lung of WT and 
Hmga2‐/‐ mice were performed as  in B and analyzed by  stereology. Error bars,  s.e.m.  (n=2  for WT and n=4  for 
Hmga2‐/‐). Asterisks as in Fig. 12A. (D) Top, Airway resistance [cmH2O/ml]. Bottom, Compliance [l/cm H2O]. Error 
bars, s.e.m. (n=4 in each group). Asterisks as in Fig. 12A. (E) Cell suspensions of adult lung of WT and Hmga2‐/‐ mice 
were  analyzed by  flow  cytometry  after  immunostaining using  SFTPC‐specific  antibody.  Error bars,  s.e.m.  (n=4). 
Asterisks as in Fig. 12A. (F) Sections of adult lung of WT and Hmga2‐/‐ mice were analyzed by confocal microscopy 
after double  immunostaining using SFTPC‐ and SCGB1A1‐specific antibodies. Arrowheads, BASCs. Scale bars, 40 
m.  (G) Cell suspensions of adult  lung of WT and Hmga2‐/‐ mice were analyzed by  flow cytometry after double 
immunostaining using SCGB1A1‐ and SFTPC‐specific antibodies. Error bars, s.e.m. (n=4). Asterisks as in Fig. 12A.    
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Hmga2−/− mice showed a reduction of ATII cells by flow cytometry analysis of single cell 
suspension of adult lung after SFTPC immunostaining (Figure 17E). ATII cells were reduced 
from 14 % (WT) to 7.56 % (P<0.01; n=4) in Hmga2−/− mice. Next, the effect of Hmga2−/− on 
one of the adult lung progenitor cell population BASCs was investigated (Figure 17F, G). 
BASCs express both Scgb1a1 and Sftpc, a trait not shared by other epithelial cells in the adult 
lung [6]. Therefore, immunostaining in sections of adult lung using SCGB1A1- and SFTPC-
specific antibodies was performed for the assessment of BASCs (Figure 17F). Hmga2−/− resulted 
in an expansion of BASCs when compared to the lung of WT mice. Moreover, flow cytometry 
analysis in cell suspension of adult lung (Figure 17G) revealed that the percentage of SFTPC- 
and SCGB1A1-positive cells increased from 0.7 % (WT) to 3.1 % (P<0.01; n=4) in Hmga2−/− 
mice. Thus, increased numbers of progenitor cells in the lung of Hmga2-/- mice generated an 
imbalance in cell differentiation that is reflected in a reduction of ATII cells, thereby affecting 
both lung morphology as well as lung functionality. 
4.2	 Hmga2	 modulates	 canonical	 WNT	 signaling	 during	 lung	
development	and	homeostasis	
4.2.1	Hmga2	knockout	led	to	enhanced	canonical	WNT	signaling	during	
lung	development			
To identify the cause of the Hmga2−/− mice lung phenotype, Affymetrix microarray-based 
expression analysis of embryonic lung of Hmga2−/− mice was performed (Figure 18A). It 
revealed an increased expression of cell cycle related genes in Hmga2−/− when compared to the 
WT mice confirming immunohistological results. In addition, it also revealed increased 
canonical WNT signaling target genes or positive regulators and reduced negative regulators in 
the embryonic lung of Hmga2−/− mice. These results indicate enhancement of canonical WNT 
signaling in Hmga2−/− that was further validated by increased activity of the CTNNB1/TCF/LEF 
WNT-reporter (BAT-GAL) in embryonic lung of the BAT-GAL: Hmga2−/− double transgenic 
mice when compared to BAT-GAL: Hmga2+/+ (Figure 18B). WB analysis of embryonic lung 
protein extracts (Figure 18C) showed increased levels of activated-beta-catenin (ABC) and 
phosphorylation of the WNT co-receptor LRP6 [129-131] after Hmga2−/− confirming 
enhancement of canonical WNT signaling. However, CTNNB1 has a dual role in both WNT 
signaling and cell adhesion processes.  
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Figure 18. Hmga2‐/‐ mice embryonic  lung showed enhanced canonical WNT signaling.  (A) Graph  represent  top 
enriched cellular pathways (P<0.05) in transcriptome analysis of Hmga2‐/‐ E18.5 lung when compared to WT. Kyoto 
Encyclopedia  of  Genes  and  Genomes  (KEGG)  based  analysis  using  DAVID  bioinformatics  tool  (left).  Magenta 
columns, pathways with increased expression (fold change1.2); Green columns, pathway with reduced expression 
(fold  change<1.2);  repli,  replication;  ma,  maturation;  JAK‐STA,  JAK‐STAT  signaling;  Toll‐lik,  Toll‐like‐receptor 
signaling; RIG, RIG‐like‐receptor signaling. Heat map (right) analysis was done using DNAStar Arraystar 11.0. Green, 
low  expression;  Magenta,  high  expression;  FC,  fold  change.  (B)  Hmga2‐/‐  enhanced  the  activity  of  the  beta‐
catenin/TCF/LEF  reporter  in  embryonic  lung  of  the  BAT‐GAL  transgenic  mice.  Beta‐galactosidase  staining  was 
performed in E14.5 lung (blue color). Representative BAT‐GAL staining is shown (n=5). Scale bars, 2mm. (C) Protein 
extracts  from WT  or Hmga2‐/‐  E18.5  lungs were  analyzed  by western blot  using  the  indicated  antibodies.  Two 
biological duplicates were analyzed (lanes 2‐3). (D) Expression analysis of the indicated genes by qRT‐PCR in E18.5 
lung of WT and Hmga2‐/‐ mice. Mycn,  v‐myc myelocytomatosis  viral  related oncogene; Fgfr2,  fibroblast growth 
factor receptor 2. Error bars, s.e.m. (n=4). Asterisks as in Fig. 12A. (E) Protein extracts from WT or Hmga2‐/‐ E18.5 
lungs were analyzed as in C using the indicated antibodies. (F) Expression analysis as in D of the indicated genes. 
(G) Sections of E14.5 lung of WT and Hmga2‐/‐ mice were analyzed by confocal microscopy using KRT‐ and CTNNB1‐ 
specific antibodies. Square  shows details at higher magnification on  the  right. Arrows  indicate nuclear CTNNB1. 
Scale bars, 40 m and 10 m (right).       
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To confirm an enhanced WNT signaling after Hmga2−/−, expression of canonical WNT targets, 
Axin2, Mycn, Fgfr2 and Bmp4 in the embryonic lung was analyzed (Figure 18D). Expression of 
canonical WNT targets increased after Hmga2−/− when compared to WT mice, demonstrating 
elevated canonical WNT signaling. WB analysis of protein extracts from embryonic lung (Figure 
18E) showed increased levels of canonical WNT targets in Hmga2−/− confirming gene expression 
analysis.  
Affymetrix microarray-based expression analysis (Figure 18A) also showed elevated expression 
of Wnt11, Wnt7b and Wnt2b in embryonic lung of Hmga2−/− mice when compared to WT. These 
results were confirmed by qRT-PCR based expression analysis (Figure 18F). Furthermore, 
immunostaining on sections of embryonic lung using CTNNB1-specific antibody (Figure 18G) 
showed increased nuclear localization of CTNNB1 in both the epithelium and the mesenchyme 
cells in Hmga2−/− when compared to WT. 
 
Figure 19. Hmga2  loss‐of‐function  (LOF)  in  embryonic  lung  explants.  (A)  Schemata of  embryonic  lung  explant 
culture experiment. Mice embryonic lungs were explanted at E12.5 and cultured for 72 h (E15.5*). Scale bars, 500 
µm. (B) Expression analysis of the indicated genes by qRT‐PCR in embryonic lungs (E12.5, E15.5) and in explanted 
lungs  (E15.5*)  as  in  A.  Error  bars,  s.e.m.  (n=4).  (C)  Lung  explants  were  treated  with  Hmga2‐  specific  siRNA. 
Expression of the  indicated genes was analyzed by qRT‐PCR. Error bars, s.e.m. (n=4). Asterisks as  in Fig. 12A. (D) 
Protein extracts of siHmga2 treated lung explants were analyzed by WB using indicated antibodies.  
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Figure  20.  Inhibition  of 
canonical  WNT  signaling 
partially  rescued  the 
Hmga2  LOF  phenotype. 
(A)  Embryonic  lung 
explants were  cultured  as 
in  Fig. 19A. Explants were 
treated  with  indicated 
siRNAs  together  with  the 
canonical  WNT  inhibitor 
dickkopf  homolog  1 
(DKK1).  Scale  bars,  500 
m. (B) Terminal branches 
and  total  branch  length 
were  quantified  at  E12.5 
and  E15.5*.  Embryonic 
lung explants were treated 
as  in A.  Error  bars,  s.e.m. 
(n=6).  Asterisks  as  in  Fig. 
12A.  (C)  Protein  extracts 
from  the  lung  explants 
treated  as  in  A  were 
analyzed  by  WB  using 
indicated  antibodies.  (D) 
Expression  analysis  of  the 
indicated  genes  by  qRT‐
PCR  in  embryonic  lung 
explants that were treated 
as  in A.  Error  bars,  s.e.m. 
(n=3).  Asterisks  as  in  Fig. 
12A.  (E)  Protein  extracts 
from  the  lung  explants 
treated  as  in  A  were 
analyzed  by  WB  using 
indicated antibodies.  
 
To confirm the causal involvement of canonical WNT signaling in mediating the effect of 
Hmga2-LOF, an organ explant culture system that mimics the normal embryonic lung 
development was used (Figure 19A-B) [24]. Depletion of Hmga2 in these organ explants using 
siRNA led to a marked impairment in branching morphogenesis when compared to control 
explants (Figure 20A). These defects during formation of bronchial and respiratory tree after 
Hmga2-LOF were validated by quantification of the total number of terminal branches and 
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branch length (Figure 20B). When E12.5 lungs were cultured for 72 hours in the presence of a 
Hmga2-specific siRNA (siHmga2), the total number of terminal branches (top) as well as the 
branch length (bottom) were reduced from 58 (siCtrl) to 34 (P < 0.001; n = 6) and from 17 mm 
(siCtrl) to 12 mm (P < 0.001; n = 6) respectively. However, treatment of the explants with the 
secreted canonical WNT inhibitor DKK1 [132] antagonized the defects caused by siHmga2 
(Figure 20A-B) reconstituting the total number of terminal branches to 51 (P < 0.01; n = 6) and 
the branch length to 14 mm (P < 0.01; n = 6). DKK1 treatment alone had also been shown to 
affect branching morphogenesis by blocking WNT signaling as previously described in 
embryonic lung explants [133]. WB analysis of protein extracts from embryonic lung explants 
(Figure 20C) showed increased levels of ABC and phosphorylated LRP6 (pLRP6) after Hmga2-
KD (Figure 20C, lane 4) demonstrating enhancement of canonical WNT signaling that was 
antagonized after DKK1 treatment (Figure 20C, lane 5). Furthermore, the partial rescue of the 
Hmga2-LOF phenotype achieved by DKK1-mediated block of WNT signaling was validated by 
expression analysis of canonical WNT targets (Figure 20D) and by WB analysis of protein 
extracts from embryonic lung explants (Figure 20E).  
4.2.2	 Hmga2	 knockout	 showed	 enhanced	 canonical	WNT	 signaling	 in	
adult	lung	
 
Adult mouse lung was analyzed to verify the enhanced canonical WNT signaling data that was 
obtained in the embryonic lung of Hmga2-/- mice. Immunostaining in sections of adult lung of 
Hmga2-/- mice showed increased levels of nuclear ABC (Figure 21A) and qRT-PCR showed 
elevated expression of canonical WNT signaling markers (Figure 21B) suggesting an 
enhancement of canonical WNT signaling in adult lung consistent with  previous results in the 
embryonic lung presented in this study.  
To verify the involvement of canonical WNT signaling in mediating the effect of Hmga2-/- in 
adult lung, shDNA mediated in vivo Hmga2-LOF experimental system was used in which Hmga2 
depletion was induced by Polyethylenimine (PEI) mediated transfection of a specific shDNA 
construct into cells of the lung epithelium after orotracheal administration of the transfection mix 
(Figure 22A) in transgenic mice in which WNT signaling is attenuated (Ctnnb1+/- mice; CMV-
Cre-,Ctnnb1tm2Ke ) [120] or blocked by Doxycycline-inducible expression Dkk1 (Dox-ind Dkk1 
mice; Rosa26rtTA, Tet (O) Dkk1) [121]. Immunostaining in sections of adult lung using 
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SCGB1A1- and SFTPC-specific antibodies was performed (Figure 22B) for the assessment of 
BASCs after shDNA mediated Hmga2 depletion. ShDNA mediated Hmga2 knockdown resulted 
in an expansion of BASCs when compared to the lung of ShCtrl treated mice. Moreover, flow 
cytometry analysis in cell suspensions of WT mice adult lung revealed that the percentage of 
SFTPC- and SCGB1A1-positive cells increased from 0.6 % (Ctrl) to 3.2 % (P<0.001; n=5) after 
shDNA mediated Hmga2 depletion supporting previous results in Hmga2-/- mice (Figure 22C) 
presented in this study. However, Hmga2-LOF in Ctnnb1+/- mice or Dox-ind Dkk1 mice 
increased the percentage of SFTPC- and SCGB1A1-positive cells to only 1.5 % (P<0.05; n=5) or 
1.2 % (P<0.05; n=5) respectively confirming the requirement of canonical WNT signaling in 
mediating the effect of Hmga2-LOF in adult lung. 
 
 
 
Figure 21. Hmga2‐/‐ enhanced canonical WNT signaling  in the adult  lung.  (A) Sections of adult  lung of Hmga2‐/‐ 
mice  were  analyzed  by  confocal  microscopy  after  double  immunostaining  using  ABC‐  and  LMNB1‐specific 
antibodies. Nuclear staining with Draq5. Scale bars, 40 m. Squares as  in Fig.11B.  (B) Expression analysis of  the 
indicated genes by qRT‐PCR in adult lung of WT and Hmga2‐/‐ mice. Error bars, s.e.m. (n=5). Asterisks as in Fig. 12A.   
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Figure 22. Transgenic inhibition of canonical Wnt signaling partially rescued the effect of in vivo Hmga2‐LOF. (A) 
In vivo  shDNA mediated Hmga2‐LOF was efficient.  Left,  schemata of  in vivo Hmga2‐LOF. Hmga2 depletion was 
induced by orotracheal application of a transfection mix containing PEI  (transfection reagent) and either control 
(shCtrl) or Hmga2‐specific (shHmga2) DNA plasmid for the production of short hairpin RNA (shDNA). PEI mediated 
transfection was performed three times (at days 0, 3 and 6) before lung harvesting (at day 10) for monitoring LOF 
efficiency. In vivo shDNA mediated Hmga2‐LOF was monitored by qRT‐PCR (Middle) and WB (Right) using HMGA2‐
specific antibodies. Error bars, s.e.m. (n=10). Asterisks as  in Fig. 12A. (B) Depletion of Hmga2  in adult  lung  led to 
expansion of BASCs  in the BADJ region. Mice were treated as  in A. At day 10, confocal microscopy of adult  lung 
sections was  performed  after  immunostaining  (Left)  using  SFTPC‐  and  SCGB1A1‐specific  antibodies  to monitor 
BASCs  (brackets) and quantified  (Right) per BADJ. Scale bars, 40 µm. Error bars, s.e.m.  (n=9). Asterisks as  in Fig. 
12A. (C) Hmga2 depletion was  induced as  in A  in adult  lung of WT mice, Ctnnb1 heterozygous mice (Ctnnb1 +/‐) 
and Doxycyclin‐inducible Dkk1‐expressing mice (Dkk1 Dox‐ind). Cell suspensions of the lung of treated mice were 
analyzed by flow cytometry using SFTPC‐ and SCGB1A1‐specific antibodies. Error bars, s.e.m. (n=5). Asterisks as in 
Fig. 12A.  
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4.2.3	HMGA2	directly	activates	Gata6	expression	and	thereby	modulates	
canonical	WNT	signaling		
GATA6 is a transcription factor that is essential for branching morphogenesis and inhibits 
canonical WNT signaling in the distal epithelium of the lung by transcriptional activation of its 
downstream target, the canonical WNT/CTNNB1 pathway antagonist Fzd2 [31, 134]. The 
defects observed after Hmga2-LOF (Figure 23A-B) were similar to the Gata6-LOF phenotype 
[29]. Therefore, whether Hmga2 directly regulates Gata6 was further investigated. 
Immunostaining on sections of embryonic lung (E14.5) using HMGA2- and GATA6-specific 
antibodies (Figure 24A) showed the presence of both proteins in the same cells of the distal lung 
endoderm. Interestingly, qRT-PCR based expression analysis in embryonic lung showed that 
Gata6 and its downstream target gene Fzd2 decreased in Hmga2-/- when compared to WT mice 
(Figure 24B). WB analysis of protein extracts from embryonic lung (Figure 24C) showed 
reduced levels of GATA6 and FZD2 after Hmga2-/- supporting gene expression analysis.  
 
Figure  23.  Hmga2‐  and  Gata6‐LOF  in 
embryonic  lung explants  led to a marked 
impairment  of  airway  epithelial 
differentiation  due  to  enhanced 
canonical WNT activity.  (A) Phenotype of 
Gata6‐LOF  in  lung explants was similar  to 
the  Hmga2‐LOF.  Top,  embryonic  lungs 
were  explanted  and  cultured  as  in  Fig. 
19A. Explants were treated with  indicated 
siRNAs.  Scale  bars,  500  m.  Bottom, 
sections of treated explants were analyzed 
by  confocal  microscopy  after 
immunostaining  using  indicated 
antibodies.  Scale  bars,  40  m.  (B) 
Expression analysis of the  indicated genes 
by qRT‐PCR  in  lung explants  treated as  in 
A. Error bars, s.e.m.  (n=4). Asterisks as  in 
Fig. 12A.  
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Figure 24. HMGA2 directly regulates Gata6 and thereby modulates Fzd2 expression. (A) Fluorescence microscopy 
of  embryonic  lung  sections  (E14.5)  after double  immunostaining using HMGA2‐  and GATA6‐specific  antibodies. 
Nuclear staining with DAPI (blue). Square shows details at higher magnification. Scale bars, 40 m. (B) Expression 
analysis of the indicated genes by qRT‐PCR in Hmga2 ‐/‐ and WT mice. Error bars, s.e.m. (n=4) and asterisks as in Fig. 
12A.  (C) Protein extracts from WT or Hmga2‐/‐ embryonic  lung  (E18.5) were analyzed by WB using the  indicated 
antibodies.  (D) Hmga2 over expression  increased Gata6 transcription. Top, Luciferase reporter assays of MLE‐12 
cells  transiently  transfected with a Gata6‐luciferase  (Gata6‐Luc)  reporter plasmid and control  (empty vector) or 
Hmga2 expression  construct. RLU, Relative  light units. Bottom, Gata6 expression was monitored by qRT‐PCR  in 
MLE‐12 cells treated as above. Error bars, s.e.m. (n=4) and asterisks as in Fig. 12A. (D) Endogenous HMGA2 binds 
to the endogenous Gata6 promoter. Top, in silico analysis of the Gata6 gene (‐631 ‐ +1 bp relative to transcription 
initiation site) revealed several HMGA2 binding elements (squares). Arrows, position of the primers used for ChIP. 
Bottom, ChIP of the Gata6 promoter using HMGA2‐specific antibody or Immunoglobulin G (IgG, negative control). 
%, percentage. Error bars, s.e.m. (n=4) and asterisks as in Fig. 12A. 
 
To investigate the effect of Hmga2 gain-of-function (GOF) on Gata6 expression, MLE-12 cells 
were transiently transfected with Hmga2 and a plasmid containing the luciferase (Luc) reporter 
gene under the control of the Gata6 promoter (Figure 24D, top). Forced expression of Hmga2 
increased more than fivefold the basal transcription of the Gata6-Luc reporter. In addition, 
expression of endogenous Gata6 increased more than twofold after Hmga2 transfection (Figure 
24D, bottom). Consistently, in silico analysis of the murine Gata6 gene (Figure 24E, top) 
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revealed several HMGA2 binding elements near the transcription initiation site. Moreover, ChIP 
in MLE-12 cells (Figure 24E, bottom) showed a direct association of endogenous HMGA2 to the 
endogenous Gata6 promoter. Thus, it was concluded that HMGA2 directly activates Gata6 gene 
expression and the enhanced WNT signaling caused by Hmga2-LOF could also be mediated by a 
reduction of the WNT signaling antagonizing proteins GATA6 and FZD2. 
 
Figure  25.  Hmga2  acts  upstream  of 
Gata6  during  WNT  signaling 
regulation.  (A)  Gata6  and  Fzd2  are 
required  for  the  effect  of Hmga2‐GOF 
on  expression  of  WNT  targets. 
Expression  analysis  of  the  indicated 
genes by qRT‐PCR  in MLE‐12  cells  that 
were  transfected  with  either  Ctrl  or 
Gata6‐  or  Fzd2‐specific  siRNA  and 
Hmga2  expression  plasmid  as 
indicated.  Error  bars,  s.e.m.  (n=4). 
Asterisks as  in Fig. 12A.  (B) Gata6‐GOF 
rescued  the  effect  of  Hmga2‐LOF  on 
expression  of WNT  targets.  Expression 
analysis of the  indicated genes by qRT‐
PCR  in  MLE‐12  cells  that  were 
transfected with either Ctrl or Hmga2‐ 
or  Fzd2‐specific  siRNA  and  Gata6 
expression  plasmid  as  indicated.  Error 
bars,  s.e.m.  (n=4).  Asterisks  as  in  Fig. 
12A.  
 
 
 
To show the requirement of Gata6 in Hmga2-mediated regulation of WNT signaling, MLE-12 
cells were transfected with Hmga2 after siRNA-mediated Gata6- or Fzd2-depletion (Figure 25A). 
Expression analysis showed that Hmga2-GOF increased the levels of Gata6 and Fzd2 whereas it 
reduced the levels of canonical WNT targets Mycn, Axin2 and Bmp4, confirming a role of 
Hmga2 in inhibition of canonical WNT signaling. Interestingly, Gata6- or Fzd2-depletion 
antagonized the effect of Hmga2-GOF on both groups of markers analyzed, indicating the 
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requirement of Gata6 and Fzd2 for the negative regulation of WNT signaling mediated by 
Hmga2. 
To determine the causal involvement of Gata6 in Hmga2-mediated regulation of WNT signaling, 
MLE-12 cells were transfected with Gata6 after siRNA-mediated Hmga2- or Fzd2-depletion 
(Figure 25B). Expression analysis showed that Hmga2- and Fzd2-LOF enhanced the expression 
of canonical WNT targets, supporting previous expression analysis in the embryonic lung of 
Hmga2-KO mice and as expected from WNT signaling antagonizing genes. Interestingly, Gata6 
transfection compensated the effect of Hmga2-LOF, but not of Fzd2-LOF.  
To rescue Hmga2-/- adult lung phenotype, a variation of the in vivo transfection method (Figure 
22A) was used to overexpress Flag-Gata6 in the lungs of WT and Hmga2-/- mice (Figure 26A). 
Using this system, transfection of a major part of the bronchiolar as well as alveolar epithelium 
was achieved. Forced expression of Flag-Gata6 in lungs of WT mice (Figure 26B) reduced the 
percentage of SFTPC- and SCGB1A1-positive cells from 0.7 % (Ctrl) to 0.4 % (P<0.01; n=3) as 
expected for a reduced WNT signaling. Importantly, Flag-Gata6 overexpression antagonized the 
effect of Hmga2-/- reducing the percentage of SFTPC- and SCGB1A1-positive cells from 3.0 % 
(Ctrl) to 1.2 % (P<0.01; n=3) showing thereby a partial rescue of the Hmga2-/- phenotype that 
was further validated by expression analysis of Fzd2 (Figure 26C) and canonical WNT targets 
(Figure 26D).    
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Figure  26.  Gata6  over  expression 
in adult  lung partially  rescued  the 
effect of Hmga2‐/‐. (A) Transfection 
of  bronchiolar  and  alveolar 
epithelium in adult mouse lung was 
induced  by  orotracheal  instillation 
of a transfection mix containing PEI 
and either an empty plasmid  (pBS, 
negative  control)  or  an  expression 
plasmid for flag tagged Gata6 (flag‐
Gata6) as  in Fig. 22A. PEI mediated 
transfection  was  performed  three 
times (days 0; 3 and 6) before  lung 
harvesting  (day  10)  for monitoring 
transfection  efficiency  by  confocal 
microscopy  by  immunostaining 
using  flag‐  and  GATA6‐  specific 
antibodies.  DAPI,  nuclear  staining. 
Scale  bars,  500  m.  (B)  Gata6 
overexpression  was  induced  in 
Hmga2‐/‐  mice  adult  lung  as  in  A. 
Cell  suspensions  of  the  lung  of 
treated mice were analyzed by flow 
cytometry  using  SFTPC‐and 
SCGB1A1‐specific  antibodies.  Error 
bars,  s.e.m.  (n=3).  Asterisks  as  in 
Fig.  12A.  (C  and  D)  Gata6 
overexpression  was  induced  in 
Hmga2‐/‐  mice  adult  lung  as  in  A. 
Expression analysis of the indicated 
genes  by  qRT‐PCR.  Error  bars, 
s.e.m.  (n=3).  Asterisks  as  in  Fig. 
12A.   
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4.3	HMGA2	mediated	Gata6	transcriptional	activation	requires	
ATM‐mediated	 histones	 phosphorylation	 and	 nucleosome	
eviction	
	4.3.1	ATM	is	required	for	HMGA2‐mediated	transcriptional	activation	of	
Gata6	
 
 A proteomic approach to identify HMGA2 interacting proteins (Figure 27A) and subsequent 
confirmation by Co-IP of endogenous proteins (Figure 27B) revealed the interaction between 
HMGA2 and, among others, the kinase ATM, the core histone variant H2AX and the linker 
histone H1. Thus, we decided to focus our attention on a potential role of ATM-mediated protein 
phosphorylation on transcriptional activation regulated by HMGA2.  
 
Figure 27. HMGA2 interacts with ATM, Histone H1 and H2AX. (A) HMGA2 interacting proteins identified by mass 
spectrometry analysis. Label free quantitation between control and HMGA2 co‐affinity precipitations. Scatter plot 
of peak intensities and label free protein quantitation. Detected proteins in Experiment 1 and Experiment 2 with a 
fold change > 2 were labeled with a red circle. (B) Endogenous HMGA2 was immunoprecipitated (IP) from nuclear 
protein extracts of HEK293T cells using either immunoglobulin G (IgG, as control) or HMGA2‐specific antibody. Co‐
immunoprecipitated proteins were analyzed by WB using the indicated antibodies. Input, 5% of material used for 
the IP. 
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Figure  28. HMGA2  is  required  for ATM‐mediated  phosphorylation  of H2AX  and H1.  (A) HEK293T  cells  stably 
expressing  flag‐tagged  H2AX  (H2AX‐flag)  were  transiently  transfected  with  either  an  Hmga2‐myc  expression 
plasmid or an empty vector. Nuclear protein extracts from transfected cells were analyzed by protein IP using an 
antibody  specific  for  phosphorylated  ATM  substrates  (ATM  subs)  or  IgG  control.  Immunoprecipitated  proteins 
were  analyzed  by  WB  using  the  indicated  antibodies.  (B)  HEK293T  cells  stably  expressing  H2AX‐flag  were 
transfected with either Ctrl or HMGA2‐specific siRNA. Nuclear protein extracts of transfected cells were analyzed 
by  IP using ATM‐specific antibody or  IgG  control.  Immunoprecipitated proteins were analyzed by WB using  the 
indicated antibodies. (C) HEK293T cells stably expressing H2AX‐flag were transiently transfected with empty vector 
or an Hmga2‐myc expression plasmid and Ctrl or HMGA2‐specific siRNA. Nuclear protein extracts of  transfected 
cells were analyzed by  IP using an antibody  specific  for ATM  subs or  IgG  control.  Immunoprecipitated proteins 
were analyzed by WB using the indicated antibodies.  
 
Immunoprecipitation using an antibody specific for phosphorylated ATM substrates revealed 
that HMGA2, H2AX and H1 are phosphorylated by ATM (Figure 28A, lanes 1-3) and HMGA2 
overexpression enhanced H2AX and H1 phosphorylation (Figure 28A, lanes 2-4). Hence to 
check the effect of HMGA2 depletion on interaction of ATM with H1 and H2AX, siRNA-
mediated HMGA2-LOF (Figure 28B) was performed. HMGA2-LOF compromised the 
interactions between ATM and the histones H2AX and H1 showing the requirement of HMGA2 
for these interactions and suggesting a role of HMGA2 as an adaptor between these proteins. 
Confirming previous reports, Co-IP using an antibody specific for phosphorylated ATM 
substrates showed that H2AX and H1 are phosphorylated by ATM (Figure 28C, lanes 1-2). 
Interestingly, HMGA2-LOF abolished ATM-mediated phosphorylation of H2AX and H1 (Figure 
28C, lane 3) demonstrating the requirement of HMGA2 for these post-translational 
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modifications. The specificity of this finding was confirmed by a partial rescue of ATM-
mediated phosphorylation of H2AX and H1 in HMGA2 depleted HEK293T cells after expression 
of the mouse Hmga2 ortholog (lane 6). 
 
Figure 29. ATM kinase activity inhibition reduced Hmga2‐induced H2AX phosphorylation. (A) HEK293T cells were 
transiently transfected with either an Hmga2‐myc expression plasmid or an empty vector. Transfected cells were 
either untreated or treated with the ATM inhibitor KU‐55933 (ATMin). Nuclear protein extracts from treated cells 
were  analyzed  by WB  using  the  indicated  antibodies.  ATMS1981ph,  phosphorylated  ATM  at  serine  1981.    (B) 
HEK293T cells were transiently transfected with an empty vector or an Hmga2 expression plasmid and Ctrl or ATM‐
specific  siRNA.  Transfected  cells  were  either  untreated  or  treated  with  the  ATMin  as  indicated.  Confocal 
microscopy of HEK293T  cells  after  immunostaining using H2AXS139ph‐specific  antibody.  Scale bars, 40 m.  (C) 
Protein extracts  from HEK293T cells transfected with Ctrl or ATM‐specific siRNA were analyzed by WB using the 
indicated antibodies.  
Transfection of Hmga2-myc in HEK293T cells (Figure 29A, B) increased the levels of 
H2AXS139ph (lane 2) in an ATM dependent manner, since treatment of the cells with the ATM 
inhibitor (ATMin) KU-55933 counteracted the effect of Hmga2 (lane 3). The inhibiting effect of 
KU-55933 on ATM was monitored by the reduction of phosphorylated ATM [135, 136]. In 
addition, neither Hmga2 transfection nor ATM inhibition altered the total level of H2AX and 
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ATM, supporting that the observed effects are related to post-translational modifications of 
H2AX and ATM.  
To investigate whether transcriptional regulation of GATA6 by HMGA2 involves ATM-mediated 
phosphorylation of H2AX and H1, the GATA6 promoter of HEK293T cells was analyzed by 
ChIP after transfection of empty vector or Hmga2 (Figure 30A). Hmga2 overexpression led to an 
enrichment of ATM, H2AXS139ph and Pol II on the GATA6 promoter. Interestingly, ATM-LOF 
either by co-transfection with siATM (Figure 29C) or by KU-55933 treatment antagonized the 
effects caused by Hmga2 transfection thereby showing the requirement of ATM for these effects.  
 
Figure  30.  ATM  is  required  for  HMGA2‐mediated  transcriptional  activation  of  GATA6.  (A)  ChIP  analysis  was 
performed  using  the  indicated  antibodies  in HEK293T  cells  that were  transiently  transfected with  a  Ctrl  or  an 
Hmga2 expression plasmid and Ctrl or ATM‐specific siRNA. Transfected cells were either untreated or treated with 
the ATMin as indicated. Enrichment of the indicated proteins on the GATA6 promoter after ChIP was monitored by 
qPCR. % of  input H2AX norm, percentage of  input normalized with H2AX; Pol  II, polymerase  II. Error bars, s.e.m. 
(n=4). Asterisks as in Fig. 12A. (B) Top, Luciferase reporter assays of HEK293T cells that were transiently transfected 
with a Gata6‐luciferase (Gata6‐Luc) reporter plasmid and either a Ctrl or an Hmga2 expression plasmid and siCtrl 
or  siATM as  indicated. Transfected  cells were either untreated or  treated with ATMin. Error bars,  s.e.m.  (n=3). 
Asterisks  as  in  Fig.  12A.  Bottom,  GATA6  expression  was  monitored  by  qRT‐PCR  in  HEK293T  cells  that  were 
transfected as in B. Error bars, s.e.m. (n=3). Asterisks as in Fig. 12A. (C) Nuclear protein extracts from HEK293T cells 
that were transfected/treated as in Fig. 29A were analyzed by WB using the indicated antibodies. 
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To determine the influence of the chromatin changes induced by Hmga2-GOF on GATA6 
expression, HEK293T cells were transiently transfected with Hmga2 and a plasmid containing 
the luciferase reporter gene under the control of the Gata6 promoter (Figure 30B, top). Forced 
expression of Hmga2 increased more than fourfold the basal transcription of the Gata6-Luc 
reporter. In addition, expression of endogenous GATA6 increased more than threefold after 
Hmga2 transfection (bottom). Consistent with ChIP results, both approaches of ATM-LOF 
counteracted the enhanced expression of the Gata6-Luc reporter as well as endogenous GATA6 
after Hmga2-GOF thereby confirming the requirement of ATM for the effects caused by Hmga2 
on GATA6 expression. WB analysis of protein extracts from HEK293T cells (Figure 30C) 
showed increased levels of GATA6 after Hmga2-GOF that were reduced after ATM inhibition.  
4.3.2	ATM‐mediated	phosphorylation	 of	H2AX	 is	 required	 for	HMGA2‐
induced	transcriptional	activation	of	Gata6	
 
H2AXS139ph is commonly used as a marker for DNA-DSB [101]. However, there is increasing 
evidence for additional functions of this histone modification [102-104, 137]. Following this line 
of ideas, the molecular mechanisms underlying HMGA2-induced chromatin modifications at the 
Gata6 promoter was investigated in more detail using HEK293T cells that stably express a flag-
tagged wild type H2AX (H2AXwt) or a mutant H2AX (H2AXS-A), in which the serine 139 was 
mutated to alanine (Figure 31A). H2AXwt and H2AXS-A were immunoprecipitated along with 
ATM in Co-IP analysis of protein extracts from both cell lines using HMGA2 specific antibody 
(lanes 2-3) showing that the interaction between HMGA2, H2AX and ATM was apparently not 
affected by the mutation. These results were confirmed by Co-IP using ATM specific antibody 
(Figure 31B). However, Co-IP using an antibody specific for phosphorylated ATM substrates 
(ATM subs; Figure 31C) showed that the S139A mutation abrogated the ATM-mediated 
phosphorylation of H2AX (lane 3) demonstrating the requirement of this amino acid residue for 
this specific post-translational modification. ChIP of chromatin from both cell lines (Figure 31D) 
showed accumulation of HMGA2, ATM and Pol II on the endogenous GATA6 promoter after 
Hmga2 transfection that was more prominent in the cells expressing H2AXwt (top). The presence 
of H2AXS-A (bottom) reduced the effects induced by Hmga2-GOF suggesting that ATM-
mediated H2AXS139ph is required for the HMGA2-induced changes in the chromatin of the 
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GATA6 promoter. Moreover, expression analysis (Figure 31E) of a Gata6-Luc reporter (top) and 
the GATA6 gene (bottom) demonstrated enhanced GATA6 expression after Hmga2-GOF only in 
cells expressing H2AXwt, correlating with ChIP results. WB analysis of protein extracts from 
both HEK293T cell lines (Figure 31F) showed increased levels of GATA6 after Hmga2-GOF 
only in an H2AXwt background (lane 2) supporting gene expression analysis.  
 
Figure 31. H2AX phosphorylation at Serine 139  is  required  for HMGA2‐mediated  transcriptional activation of 
GATA6.  (A) Nuclear protein extracts  from HEK293T cells stably expressing H2AXwt or H2AXS‐A was analyzed by  IP 
using an HMGA2‐specific antibody or  IgG control.  Immunoprecipitated proteins were analyzed by WB using  the 
indicated  antibodies.  (B) Nuclear protein  extracts  from HEK293T  cells  stably  expressing H2AXwt or H2AXS‐A was 
analyzed by IP using an ATM‐specific antibody or IgG control. Immunoprecipitated proteins were analyzed by WB 
using the indicated antibodies. (C) Nuclear protein extracts from HEK293T cells stably expressing H2AXwt or H2AXS‐A 
was analyzed by  IP using an antibody  specific  for ATM  subs or  IgG  control.  (D) HEK293T  cells  stably expressing 
either H2AXwt (top) or H2AXS‐A (bottom) were transiently transfected with either Ctrl or Hmga2 expressing plasmid. 
Chromatin was isolated 48 hours after transfection and analyzed by ChIP using the indicated antibodies. Error bars, 
s.e.m. (n=3). Asterisks as  in Fig. 12A. (E) Top, Luciferase reporter assays of HEK293T cells stably expressing either 
H2AXwt  or  H2AXS‐A  were  transiently  transfected  with  a  Gata6‐Luc  reporter  plasmid  and  control  or  Hmga2 
expression construct. Error bars, s.e.m. (n=3). Asterisks as  in Fig. 12A. Bottom, GATA6 expression was monitored 
by qRT‐PCR  in HEK293T cells  that were  transfected as  in D. Error bars, s.e.m.  (n=6). Asterisks as  in Fig. 12A.  (F) 
Nuclear protein extracts from HEK293T cells that were transfected as in E were analyzed by WB using the indicated 
antibodies.  
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4.3.4	 ATM‐mediated	 phosphorylation	 of	 H1	 is	 required	 for	 HMGA2‐
induced	transcriptional	activation	of	Gata6	
To investigate the molecular mechanism underlying the replacement of H1 by HMGA2, 
expression constructs for a myc-tagged wild type H1 (H1wt) or a mutant H1 (H1S-A), in which the 
serine 65 was mutated to alanine was used (Figure 32A). Co-IP analysis using HMGA2 specific 
antibody and protein extracts from HEK293T cells transfected with the empty vector (Ctrl) or 
these expression constructs revealed that both H1wt and H1S-A were immunoprecipitated along 
with ATM (lanes 2-3) supporting that the interaction between HMGA2, H1 and ATM was 
apparently not affected by the mutation. These results were confirmed by Co-IP using ATM 
specific antibody (Figure 32B). However, Co-IP using the ATM subs antibody (Figure 32C) 
showed that the S65A mutation abrogated the ATM-mediated phosphorylation of H1 (lane 3) 
demonstrating the requirement of this amino acid residue for this specific post-translational 
modification. ChIP of chromatin from HEK293T cells that were transfected with H1wt or H1S-A 
(Figure 32D) showed accumulation of HMGA2, ATM and Pol II on the endogenous GATA6 
promoter after Hmga2-GOF that was more prominent in the cells expressing H1wt (top). The 
presence of H1S-A (bottom) reduced the effects induced by Hmga2-GOF suggesting that ATM-
mediated phosphorylation of H1 at S65 is required for the HMGA2-induced changes in the 
chromatin of the GATA6 promoter. Moreover, expression analysis (Figure 32E) revealed twofold 
enhanced GATA6 expression after Hmga2-GOF only in cells that were transfected with H1wt 
correlating with previous ChIP results. Western blot analysis of protein extracts from HEK293T 
cells (Figure 32F) showed increased levels of GATA6 after Hmga2-GOF only in an H1wt 
background supporting gene expression analysis. 
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Figure 32. Histone H1 phosphorylation at Serine 65 is required for HMGA2‐mediated transcriptional activation of 
GATA6. (A) Nuclear protein extracts from HEK293T cells transiently transfected with H1wt or H1S‐A was analyzed by 
IP using an HMGA2‐specific antibody or IgG control. Immunoprecipitated proteins were analyzed by WB using the 
indicated antibodies. (B) Nuclear protein extracts from HEK293T cells transiently transfected as in A were analyzed 
by IP using an ATM‐specific antibody or IgG control. Immunoprecipitated proteins were analyzed by WB using the 
indicated antibodies. (C) Nuclear protein extracts from HEK293T cells transiently transfected as in A were analyzed 
by IP using an antibody specific for ATM subs or IgG control. (D) HEK293T cells transiently transfected with either 
H1wt  (top)  or H1S‐A  (bottom)  and were  co‐transfected with  Ctrl  or  Hmga2  expression  plasmid.  Chromatin was 
isolated 48 hours after transfection and analyzed by ChIP using the  indicated antibodies. Error bars, s.e.m. (n=3). 
Asterisks as in Fig. 12A. (E) GATA6 expression was monitored by qRT‐PCR in HEK293T cells that were transfected as 
in D. Error bars, s.e.m.  (n=6). Asterisks as  in Fig. 12A.  (F) Nuclear protein extracts  from HEK293T cells  that were 
transfected as in E were analyzed by WB using the indicated antibodies.  
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	4.3.5	 HMGA2	 activates	 Gata6	 expression	 via	 ATM‐mediated	
phosphorylation	of	H2AX	and	H1			
 
Two transgenic mouse lines Hmga2-/- [118] and Hmga2 overexpression (GOF) [119] were used 
to confirm in vitro data. WB analysis of protein extracts from mouse embryos at E18.5 (Figure 
33A) demonstrated the effect of both transgenic modifications on HMGA2 levels. Hmga2-/- 
abolished HMGA2 (Figure 33A, lanes 2-3) whereas transgenic Hmga2-GOF increased HMGA2 
levels (Figure 33A, lanes 5-6). Interestingly, Co-IP using the ATM subs antibody (Figure 33B) 
showed that Hmga2-/- reduced H1- and H2AX-phosphorylation (Figure 33B, lane2) whereas 
transgenic Hmga2-GOF induced the opposite effect (Figure 33B, lane3). The total levels of H1 
and H2AX were not affected in both mice lines thereby validating that the observed effects were 
indeed related to these post-translational modifications. In addition, WB of protein extracts of 
WT and both transgenic mice lines using H2AXS139ph antibody confirmed presented results 
(Figure 33A). ChIP using HMGA2- and ATM-specific antibodies and chromatin isolated from 
WT and both transgenic lines (Figure 33C) showed reduced association of HMGA2 and ATM to 
the Gata6 promoter in Hmga2-/- whereas increased association of both proteins to the same 
promoter in transgenic Hmga2-GOF mice. Accordingly with the ATM ChIP results, decrease of 
H1- and H2AX-phosphorylation at the Gata6 promoter in Hmga2-/- (Figure 33D, top; Figure 
33E, left) was detected whereas the opposite resulted from the analysis of Hmga2-GOF 
chromatin by sequential ChIP (ChIP-reChIP) using ATM subs and subsequently H1 or H2AX 
antibodies. These results were confirmed by ChIP and after inverting the order of antibodies used 
for ChIP-reChIP (Figure 33D, bottom; Figure 33E, right) and using H2AXS139ph antibody 
(Figure 33F). Consistently with presented in vitro data, transgenic Hmga2-GOF increased the 
association of Pol II to the Gata6 promoter when compared to WT mice (Figure 33C) whereas 
Hmga2-/- induced the reverse effect. Finally, Gata6 expression analysis (Figure 33G) showed 
more than fivefold increase in Hmga2-GOF and 50% decrease in Hmga2-/- when compared to 
WT mice confirming presented in vivo ChIP results and validating presented in vitro data.   
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Figure 33. HMGA2  activates Gata6  expression  via ATM‐mediated phosphorylation of H2AX  and H1.  (A)  Lung 
protein extracts from WT, Hmga2‐KO and Hmga2‐GOF mice were analyzed by WB using the indicated antibodies. 
Two animals per transgenic mice  line were analyzed. (B) Nuclear protein extracts from of WT, KO and GOF mice 
lung were analyzed by  IP using an antibody  specific  for ATM  subs or  IgG, control.  Immunoprecipitated proteins 
were analyzed by WB using the indicated antibodies. Input, 5% of material used for the IP. (C) Chromatin from WT, 
KO and GOF mice lung was analyzed by ChIP using the indicated antibodies. Error bars, s.e.m. (n=4). Asterisks as in 
Fig. 12A.  (D) Chromatin  from WT, KO and GOF mice  lung was analyzed by sequential ChIP using  first ATM subs 
(Top) or H1 (Bottom) antibody. The precipitated chromatin was further analyzed by a second ChIP (reChIP) using 
H1 (Left) or ATM subs (Right) antibody as indicated. Error bars, s.e.m. (n=4). Asterisks as in Fig. 12A. (E) Chromatin 
from WT,  KO  and GOF mice  lung was  analyzed by  sequential ChIP using  first ATM  subs  (Left) or H2AX  (Right) 
antibody.  The  precipitated  chromatin  was  further  analyzed  by  reChIP  using  H2AX  (Left)  or  ATM  subs  (Right) 
antibody as indicated. Error bars, s.e.m. (n=4). Asterisks as in Fig. 12A. (F) Chromatin from WT, KO and GOF mice 
lung was  analyzed by ChIP using  the  indicated  antibodies. Error bars,  s.e.m.  (n=4). Asterisks  as  in  Fig. 12A.  (G) 
Gata6 expression was monitored by qRT‐PCR in WT, KO and GOF mice lung. Error bars, s.e.m. (n=4). Asterisks as in 
Fig. 12A.   
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	4.3.6	 HMGA2‐induced	 transcriptional	 activation	 of	 Gata6	 implicates	
promoter‐specific	nucleosome	eviction	
 
 
 
Figure 34. HMGA2‐induced transcriptional activation of Gata6 implicates promoter‐specific nucleosome loss. (A) 
Schematic  representation  of  the  Gata6  gene.  The  structure  is  conserved  in  human  and  mouse.  The  relative 
location of  the primers used  for ChIP  in  the promoter  (P)  and  in  the  intragenic  region  (I)  is  shown.  Exons  are 
represented as black boxes (untranslated region) and white boxes (coding region). ATG, translation initiation start. 
(B) Chromatin from WT, KO and GOF mice lung was analyzed by ChIP using the indicated antibodies. P, promoter; I, 
intragenic  region. Error bars,  s.e.m.  (n=3). Asterisks as  in Fig. 12A.  (C) Chromatin  from HEK293T cells  that were 
transfected/treated as  in Fig. 30A was analyzed by ChIP using  the  indicated antibodies. Error bars, s.e.m.  (n=3). 
Asterisks as  in Fig. 12A.  (D) Chromatin  from HEK293T cells that were transfected as  in Fig. 31D was analyzed by 
ChIP using the indicated antibodies. Error bars, s.e.m. (n=3). Asterisks as in Fig. 12A. (E) Chromatin from HEK293T 
cells that were transfected as  in Fig. 32D was analyzed by ChIP using the  indicated antibodies. Error bars, s.e.m. 
(n=3). Asterisks as in Fig. 12A.  
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A schematic representation of the Gata6 gene is shown in Figure 34A. To investigate the effect 
of HMGA2 on the chromatin structure of the Gata6 gene, the promoter (P) and an intragenic (I) 
region of Gata6 was analyzed by ChIP using antibodies specific for different histones and 
chromatin from Hmga2-/-, Hmga2-GOF and WT mice (Figure 34B). Hmga2-/- (top) increased the 
levels of linker histone H1 and core histones H3, H4 and H2B in the Gata6 promoter without 
affecting the levels of histones in the intragenic region analyzed, suggesting that the effect was 
specific for the promoter. Interestingly, Hmga2-GOF (bottom) caused the contrary effect 
reducing the levels of all histones analyzed specifically in the Gata6 promoter. Transfection of 
Hmga2 into HEK293T cells (Figure 34C) also reduced the histone occupancy specifically in the 
GATA6 promoter confirming presented in vivo data in Hmga2-GOF mice. Furthermore, the 
effect caused by Hmga2-GOF was antagonized after ATM-LOF by siATM or ATMin showing 
the requirement of ATM. Moreover, H2AXS-A (Figure 34D, bottom) and H1S-A (Figure 34E, 
bottom) blocked the histone eviction at the Gata6 promoter induced by Hmga2 thereby 
supporting that ATM-mediated phosphorylation of the mutated serines in their respective 
histones is required for the effects caused by Hmga2-GOF. Transient transfection of Hmga2 
induced release of linker histone H1 and core histones from the GATA6 promoter (P) only in 
cells expressing H2AXwt (Figure 34D, top) or H1wt (Figure 34E, top). The levels of histones in 
the Gata6 intragenic region analyzed remained unaltered upon Hmga2 overexpression, 
confirming that the effect is specific to the promoter.  
These data were further confirmed using an experimental system in which the Gata6 promoter 
was in vitro reconstituted into chromatin using recombinant histones and nuclear protein extracts 
from HEK293T cells (Figure 35A-D). Hmga2-overexpression induced histones release (Figure 
35C, lane 8) that was blocked by ATMin (Figure 35C, lane 10). Interestingly, ATM binds the in 
vitro reconstituted chromatin only after Hmga2-GOF (Figure 35C, lanes 5 and 7) supporting 
previously presented data (Figures 30A and 33C) and suggesting a role of HMGA2 as adaptor. 
However, ATMin blocked Hmga2-mediated ATM binding to the chromatin (Figure 35, lane 9) 
supporting the requirement of the kinase activity and suggesting an ATM activation by auto-
phosphorylation. Furthermore, these results were confirmed by ChIP of the Gata6 promoter in 
vitro reconstituted in chromatin (Figure 35D). 
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Figure  35.  HMGA2‐induced  transcriptional  activation  of  Gata6  implicates  promoter‐specific  nucleosome 
eviction. (A) Schematic diagram of analysis of in vitro reconstituted polynucleosomes by western blot and ChIP. An 
850 bp fragment of the Gata6 promoter was amplified by PCR using a biotinilated forward primer and coated to 
Streptavidin Dynabeads. The DNA loaded beads were used for in vitro reconstitution into chromatin by salt dialysis 
method using  recombinant  core histones.  In  vitro  reconstituted polynucleosomes were  incubated with nuclear 
extracts of HEK293T cells. After  incubation, chromatin was separated using the magnetic beads and subjected to 
western blot and ChIP. (B) Quality of in vitro reconstituted polynucleosomes was analyzed by Mnase accessibility 
assay. Reconstitution of DNA  into polynucleosomes  (left) protects  the naked DNA  (right)  from Mnase digestion. 
Min, minutes; L, 100bp DNA ladder. Arrowheads show the positions of mono‐, tri‐ and pentanucleosomes. (C) WB 
analysis was performed using the indicated antibodies in the chromatin separated from beads (B) and supernatant 
(S)  after  incubation with  nuclear  extracts  of HEK293T  cells  that were  transiently  transfected with  a  Ctrl  or  an 
Hmga2‐myc  expression  plasmid.  Transfected  cells  nuclear  extracts  were  either  untreated  or  treated  with  the 
ATMin  as  indicated.  Representative  blots  were  shown.  (D)  ChIP  analysis  was  performed  using  the  indicated 
antibodies  in  the chromatin  that was separated  from beads after  incubation with nuclear extracts  (Nuc Prot) of 
HEK293T cells that were transiently transfected with a Ctrl or an Hmga2‐myc expression plasmid. Nuclear extracts 
were  either untreated or  treated with ATMin  as  indicated.  Enrichment of  the  indicated proteins on  the Gata6 
promoter after ChIP was monitored by qPCR. Error bars, s.e.m. (n=3). Asterisks as in Fig. 12A. 
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	4.3.7	 ATM‐mediated	 H1S65ph	 precedes	 H2AXS139ph	 during	 HMGA2‐
induced	Gata6	transcriptional	activation	
 
To create proteins that mimic the biological activity of phosphorylated proteins, we substituted 
S65 and S139 in H1 and H2AX respectively by aspartic acid (H1S-D and H2AXS-D). Transfection 
of HEK293T with H1S-D or/and H2AXS-D (Figure 36A, top) increased GATA6 expression 
minimally. The increase of GATA6 expression by these phosphomimetic mutants became more 
significant when Hmga2 was co-transfected. Interestingly, the inhibiting effect of ATMin on 
Hmga2-enhanced GATA6 expression (Figure 36A, bottom) was overcome by H1S-D and H2AXS-D 
single- or co-transfection supporting that ATM-catalyzed H1S65ph and H2AXS139ph mediate 
the enhancing effects of Hmga2 on GATA6 expression. 
To determine the order of events of GATA6 activation, HEK293T cells were transfected with the 
phosphomimetic mutants (H1S-D and H2AXS-D) together with the H1S-A and H2AXS-A mutants in 
which ATM-mediated phosphorylation is prevented. Transfection of H1S-D alone or in 
combination with Hmga2 increased GATA6 expression only in the presence of H2AXwt (Figure 
36B). H2AXS-A blocked the enhancing effect of H1S-D and Hmga2 supporting that H2AXS139ph 
is required for GATA6 activation and suggesting that is downstream of HMGA2 and H1S65ph. 
Consistent with this interpretation, H2AXS-D was not only able to increment GATA6 expression 
alone or in combination with Hmga2 (Figure 36C), but it was also able to overcome the blocking 
effect of H1S-A on Hmga2-enhanced GATA6 expression supporting that H2AXS139ph is 
downstream of HMGA2 and H1S65ph. Furthermore, ChIP of the GATA6 promoter revealed 
accumulation of H2AXS139ph after Hmga2-GOF (Figure 36D) that was blocked by H1S-A 
supporting the requirement of H1S65ph and suggesting that this post-translational modification 
precedes H2AXS139ph. 
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Figure 36. ATM‐mediated H1S65ph precedes H2AXS139ph during HMGA2‐induced transcriptional activation. (A) 
HEK293T cells that were treated with DMSO (solvent control, top) or ATMin (bottom) were transiently transfected 
with either Ctrl or Hmga2 and/or H1S‐D and/or H2AXS‐D plasmid as indicated. GATA6 expression was monitored by 
qRT‐PCR. Error bars,  s.e.m.  (n=3). Asterisks as  in  Fig. 12A.  (B) HEK293T  cells  stably expressing either H2AXwt or 
H2AXS‐A was transiently transfected with Ctrl or Hmga2 and/or H1S‐D plasmid. GATA6 expression was monitored by 
qRT‐PCR. Error bars, s.e.m. (n=3). Asterisks as in Fig. 12A. (C) HEK293T cells transiently expressing H1wt or H1S‐A was 
co‐transfected with Ctrl or Hmga2  and/or H2AXS‐D  as  indicated. GATA6  expression was monitored by qRT‐PCR. 
Error bars, s.e.m. (n=3). Asterisks as in Fig. 12A. (D) Chromatin from HEK293T cells that were transfected as in Fig. 
32D was analyzed by ChIP using H2AXS139ph and H2AX‐specific antibodies. Error bars, s.e.m. (n=3). Asterisks as in 
Fig. 12A.  
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Chapter 5: DISCUSSION & CONCLUSION 
 
HMG family member proteins are non-histone chromatin associated proteins having a key role in 
coupling signaling pathways to chromatin [32, 138, 139]. Several lines of evidence have 
underlined their role in development and disease [41, 47-50, 52-55, 65, 70, 71]. HMGA2, a 
member of HMGA family proteins having roles during lung development and homeostasis, have 
not been investigated before. Thus, the topic questioned in this thesis is of significant 
importance.     
5.1	HMGA2	 is	 required	 for	 proper	 distal	 epithelial	 cell	 differentiation	
during	lung	development	and	homeostasis	
 
 Hmga2 was originally identified in the genome wide siRNA based LOF screen, which was 
carried out to identify novel regulators of lung epithelial cell lineage during lung development. 
To validate this screen, Hmga2 expression pattern was analyzed in mouse embryonic lung by 
three independent techniques, qRT-PCR, RNA in situ hybridization and immunofluorescence. 
Hmga2 mRNA levels were high during early stages of lung development (Figure 11A, B); in 
which cells are undifferentiated, and decreased as lung development progressed, coincident with 
cell differentiation. Interestingly, a slight increase of Hmga2 expression at E18.5 was detected 
(Figure 11A) that matches with the establishment of a bipotent progenitor cell population in the 
distal epithelium [140]. Later, Hmga2 expression was reduced to a basal level in adult lung 
which correlate with previous reports in which HMGA2 was shown to be present at high levels 
in various undifferentiated tissues during embryonic development and its levels were strongly 
reduced in the corresponding adult tissues [40, 65, 110, 141, 142].  
Sftpc is one of the most specific known markers of lung epithelial cell lineage in distal airways 
[11], hence in the LOF screening, a luciferase reporter gene under the control of the Sftpc 
promoter had been used. The co-localization of HMGA2 and SFTPC in same cells of the 
embryonic lung (Figure 13A) and reduced expression of Sftpc in the Hmga2-/- mice embryonic 
lung when compared to WT (Figure 12G, H) validated the screening.  This finding was 
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interesting in the context of distal epithelial airways development hence further investigation was 
needed to understand the function of HMGA2 in this process. 
Hmga2-/- mice embryos showed reduced body size compared to wild type embryos at E18.5 
(Figure 12A) consistent with previous reports in which Hmga2−/− mice had a pygmy phenotype 
due to reduced expression of Igf2bp2 [63, 65, 66]. Prior to this study, the lung of Hmga2−/− mice 
was not analyzed. Hmga2−/− mice embryonic lung showed an expansion of the mesenchyme at 
the expense of the epithelium (Figure 12E, F). To address this point, cell proliferation analysis 
was performed in epithelial and mesenchymal cells of Hmga2−/− mice embryonic lung (Figure 
14A-D). This showed an increased cell proliferation in mesenchymal cells. Even though cell 
proliferation was more prominent in mesenchymal cells, increased epithelial cell proliferation 
was also observed (Figure 14 A-D). To understand this observation, cell proliferation was 
analyzed in distal epithelial differentiated cells and progenitor cells (Figure 15A, B). This 
showed an increased cell proliferation in epithelial progenitor cells and no significant change in 
distal epithelial differentiated cells. In addition, apoptosis analysis (Figure 16A, B) also showed 
increased epithelial cell apoptosis and no significant change in mesenchymal cell apoptosis 
confirming the expansion of the mesenchyme, hence supporting distal lung epithelial 
differentiation defect in Hmga2−/− mice.   
Detailed analysis of Hmga2−/− mice adult lung also confirmed that Hmga2 is required for proper 
distal epithelial cell differentiation not only during embryonic lung development but also in the 
adult lung homeostasis. In both cases, Hmga2−/− led to increased progenitor cells and defective 
epithelial cell differentiation (Figure 15A, B and Figure 17E-G). Increased numbers of 
progenitor cells (Figure 15B and Figure 17F, G) in the lung of Hmga2-/- mice generated an 
imbalance in cell differentiation that was reflected in a reduction of alveolar type II cells (Figure 
15A, B and Figure 17E), thereby affecting both lung morphology as well as lung functionality 
(Figure 17B-D). These data correlate with previous reports where HMGA2 was shown to be 
required for adipogenesis, neurogenesis, spermatogenesis, cardiac and skeletal muscle 
development and their proper functions [47, 48, 65, 68-71].    
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5.2	 HMGA2	 modulates	 canonical	 WNT	 signaling	 during	 lung	
development	and	homeostasis	
 
To identify potential molecular mechanism of HMGA2 for lung development and homeostasis, 
Affymetrix microarray-based expression analysis of Hmga2-/- and WT mice embryonic lung at 
E18.5 was performed (Figure 18A). This revealed an increased expression of either target or 
positive regulators of canonical WNT signaling pathway in the embryonic lung of Hmga2-/- mice. 
This was further confirmed by several independent techniques as qRT-PCR, WB and 
immunostaining as well as by using WNT reporter BAT-GAL mice (Figure 18 B-G). Taken 
together, this study showed that Hmga2-/- led to increased canonical WNT signaling resulting not 
only in defective epithelial differentiation but also in increased numbers of progenitor cells in the 
embryonic and adult lung.    
 
Figure 37. Model: HMGA2 regulates canonical WNT signaling at different points of the pathway. Regulation of 
the secreted WNT glycoproteins (Wnt2b, Wnt7b and Wnt11) mediates the paracryne effect on the mesenchyme of 
the embryonic lung. In addition, HMGA2‐mediated regulation of Gata6 is a key process in fine‐tuning the activity of 
canonical WNT signaling in developing airway epithelium. X, unknown transcription factors.    
 
Hmga2-/- led to enhanced canonical WNT signaling due to an increase of secreted WNT 
glycoproteins as well as a reduction of the WNT signaling antagonizing proteins, GATA6 and 
FZD2, thereby supporting that HMGA2 regulates WNT signaling at different points of the 
pathway (Figure 37). The causal involvement of canonical WNT signaling in mediating the 
effect of Hmga2-LOF was demonstrated by the DKK1-induced rescue of Hmga2-LOF in 
embryonic lung explants (Figure 20A-E). In addition, it was also shown in adult lung that 
transgenic mice where WNT signaling is attenuated (Ctnnb1+/- mice; CMV-Cre-,Ctnnb1tm2Ke ) 
[120] or blocked by Doxycycline-inducible expression of Dkk1 (Dox-ind Dkk1 mice; 
Rosa26rtTA, Tet (O) Dkk1) [121] rescued the Hmga2-LOF effect (Figure 22C).  
  
	 DISCUSSION	AND	CONCLUSION	
69
Directly regulation of Gata6 by HMGA2 was shown by several independent techniques such as 
qRT-PCR, WB, immunostaining, luciferase assay and ChIP (Figure 24A-E). It was reported that 
GATA6 positively regulates Fzd2 expression which results in blocking canonical WNT signaling 
in lung epithelial cells to control balance between progenitor expansion and lung epithelial 
differentiation [31]. HMGA2-mediated regulation of Gata6 seems to be a key process in fine-
tuning the activity of canonical WNT signaling in airway epithelium. The sequential order of 
events suggested in this study model (Figure 37) in which Hmga2 acts upstream of Gata6 was 
strongly supported by the fact that Hmga2-/- reduced expression of Gata6 and its downstream 
target gene Fzd2 (Figure 24B, C) as well as by the Gata6-mediated rescue experiments of 
Hmga2-LOF in MLE-12 cells (Figure 25B) and in adult lung (Figure 26B-D).   
Hmga2-/- increased cell proliferation not only in the lung epithelium, where Hmga2 is expressed, 
but also in the mesenchyme, suggesting a paracrine effect that could be explained by increased 
expression of the secreted components of WNT signaling. HMGA2 is known to activate 
transcription, the increased expression of Wnt2b, Wnt7b and Wnt11 after Hmga2-/- suggest the 
participation of a transcription inhibitor that could block the expression of these secreted 
components of WNT signaling and whose expression could be regulated by HMGA2 (Figure 
37). Interestingly, analysis of the Wnt7b promoter showed that deletion of the region between 
−1,005 bp and −829 bp relative to the second transcription start site increased significantly the 
basal transcription activity of a Wnt7b-luciferase reporter [23] suggesting that the binding 
element of a putative transcription inhibitor was deleted in this construct.      
The phenotypes of Hmga2- and Gata6-LOF in embryonic lung explants are very similar (Figure 
23A-B). However, the milder phenotype observed in the embryonic lung of Hmga2-/- mice when 
compared either with the Gata6-/- or the phenotype induced after Hmga2-KD in embryonic lung 
explants might be explained by redundancy in the function between Hmga2 and Hmga1, other 
member of the HMGA protein family. Hmga1 transcript was reduced after Hmga2-LOF (Figure 
19C) but not affected in the Hmga2-/- mice (Figure 12C). Hmga1 might compensate the Hmga2-/-, 
thereby avoiding lethality at early embryonic stages, as it is the case after Gata6-/- [143, 144], or 
soon after birth due to defects in the lung, as it is the case after lung epithelium-specific ablation 
of Gata6 [31]. To support this speculation, previous report have shown that Hmga2/Hmga1 
double knockout mice showed embryonic lethality [145] however individually Hmga2-/- mice or 
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Hmga1-/- mice did not show embryonic lethality [66, 146]. In addition, the expansion of the 
mesenchyme in the embryonic lung after Hmga2-/- and the apparent increase of epithelium in 
embryonic lung explants after Hmga2-KD might be explained by the differences of both LOF-
systems. In the transgenic approach Hmga2-LOF takes place soon after fertilization and affects 
lung development from the initial stages of lung bud formation, whereas in the explant culture 
the LOF starts at E12.5 thereby reducing the rather indirect effect on the mesenchyme and 
making the effect on the epithelium more dominant.  
Organ regeneration requires a proper balance between self-renewal and differentiation of tissue 
specific progenitor cells. This study suggests the possible role of Hmga2 in the adult lung 
controlling the balance between BASCs expansion and differentiation (Figure 17E-G) by 
modulating the canonical WNT signaling (Figure 21A, B). BASCs represent one of several 
regional progenitor cell populations in the adult lung and are responsible for regeneration of 
bronchiolar and alveolar epithelium during homeostatic turnover and in response to injury [5, 6]. 
These data are consistent with previous studies, where it was shown that canonical WNT 
signaling is activated upon lung epithelial regeneration, and lung epithelium-specific ablation of 
Gata6 enhanced canonical WNT activity which led to a premature and increased numbers of 
BASCs [31]. In addition, canonical WNT signaling has also been implicated in different 
regenerative processes including zebrafish tail regeneration, zebrafish cardiac regeneration and 
expansion of anterior heart field progenitors in mammals [147, 148].  
HMGA2 regulates Gata6 and Fzd2 expression (Figure 24 B, C). FZD2 acts as a negative 
regulator of canonical WNT signaling in lung epithelium. Given the ability of these proteins to 
modulate canonical WNT signaling in the lung, it may be possible to use them as potential 
targets to activate this pathway to increase repair and regeneration after lung injury. However, 
due to the fact that HMGA2, WNT signaling and BASCs have been involved in lung cancer [6, 
54, 149] one has to be careful before modulating the WNT pathway for this purpose.  
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5.3	 HMGA2‐induced	 transcription	 requires	 ATM‐mediated	 histones	
phosphorylation	and	nucleosome	eviction	
 
This study deciphered the mechanism of transcriptional regulation mediated by the HMGA2. 
HMGA2 regulates the transcription of its target genes by modulating the chromatin structure and 
by recruiting other proteins to the transcription regulatory complex [40], However, precise 
molecular events are not well understood therefore the molecular mechanism of HMGA2-
mediated transcriptional regulation of the Gata6 promoter was investigated. 
This study argues for a model (Figure 38) in which ATM-mediated phosphorylation of H1 and 
H2AX requires HMGA2 and increases after Hmga2-GOF. On the other hand, HMGA2-induced 
transcriptional activation of Gata6 requires ATM-mediated phosphorylation of both histones. 
Furthermore, the evidence for the sequential order of events was presented in which H1S65ph 
precedes H2AXS139ph and both are a prerequisite for the subsequent disassembly of promoter-
associated nulceosomes and transcriptional activation. The presented in vitro data were 
confirmed in vivo using two transgenic mice lines, one for Hmga2-LOF [118] and the other for 
Hmga2-GOF [119].  
 
Figure 38. Model: HMGA2‐induced  transcriptional activation of 
GATA6 requires ATM‐mediated phosphorylation of histones and 
implicates  nucleosome  eviction.  HMGA2  (purple  hexagon) 
dependent  ATM  (yellow  oval)  mediated  phosphorylation  (red 
circle) of H1 induces the release of linker histone H1 (green oval) 
from  the  chromatin.  Further HMGA2 dependent ATM mediated 
phosphorylation of H2AX  induces release of promoter‐associated 
nucleosomes to facilitate the accessibility of regulatory elements 
to  transcription  initiation  factors.  Transcription  initiation  factors 
(green hexagon and blue oval) bind  to  their regulatory elements 
and enhance transcription (black arrow) of target genes. Adatped 
[150].  
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HMGA proteins were shown to dynamically compete with H1 for binding to the linker DNA 
thereby loosening the chromatin [71, 91, 92]. In addition, displacement of H1 during the initial 
steps of gene activation has been reported [151]. However, presented data in this study provides 
new mechanistic insights linking these two events. This study demonstrated that ATM-mediated 
H1S65ph is required for HMGA2-induced Gata6 activation (Figure 32D-F, Figure 33D, G and 
Figure 34E) which correlate with previous reports in which phosphorylation of H1 by CDK2 has 
been associated with hormone dependent transcriptional activation [151, 152].  
H2AXS139ph is perhaps one of the most widely used biomarkers for DNA damage [101]. 
However, there is increasing evidence for additional functions of this histone modification. 
ATM-mediated H2AXS139ph plays a role during recombination of variable (V), diversity (D) 
and joining (J) segments which is the basis for antigen receptor diversity during lymphocyte 
differentiation [103]. H2AXS139ph is important during angiogenesis since hypoxia-driven 
neovascularization was significantly reduced in endothelial-specific H2AX-deficient mice and 
hypoxia induced H2AXS139ph in primary cultures of human endothelial cells [102]. Another 
study demonstrated that high basal levels of H2AXS139ph are required for stem cell self-
renewal [104]. Findings of this study support a role of H2AXS139ph during Hmga2-induced 
gene activation that involves promoter specific nucleosome eviction to enhance transcription by 
Pol II (Figure 31D-F; Figure 33E-G and Figure 34D). Accordingly, it has been reported that 
promoters of active (or poised) genes are either nucleosome-free or marked with unstable 
nucleosomes that contain specific histone variants such as H3.3 and H2A.Z [153]. Although 
H2AX does not affect nucleosome conformation, it has a de-stabilizing effect that is enhanced by 
its phosphorylation and results in an impaired linker histone H1 binding [154], correlating with 
results presented in this study. Furthermore, the histone chaperone complex FACT catalyzes 
integration of H2AX into nucleosomes [155], induces disassembly of promoter-associated 
nucleosomes and enhances transcriptional activation. Interestingly, yeast FACT is a 
heterodimeric protein complex of Spt16 and Pob3 that interacts and functionally cooperates with 
the HMG1-like protein Nhp6 [156]. In addition, it has been reported that HMGA1 interacts with 
the multiprotein complex Mediator and the general transcription factor TFIID to form, together 
with Pol II, a functional pre-initiation complex on the core promoter during transcription 
initiation [45]. In summary, there are several lines of evidence that together with presented work 
in this thesis support a role of HMGA proteins and the chromatin modifications promoted by 
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them during transcription initiation by inducing promoter specific nucleosome disassembly and 
thereby facilitating the DNA access to the general transcription machinery.  
HMGA2, ATM, H1 and H2AX have been related to biological events in which DNA-dependent 
processes as repair, replication, recombination and transcription are involved. Although 
packaging of the genome into chromatin constitutes a barrier for all these processes, the 
chromatin structure offers the possibility for a controlled implementation of all these processes. 
However, controlled chromatin disassembly might involve intermediates with single or even 
double strand breaks that might compromise the integrity of DNA. Thus, there must be 
mechanisms that ensure the integrity of the genome during opening of the chromatin. This 
perspective might explain the fact that proteins and histone modifications that were initially 
characterized during DNA repair also play a role during transcription, recombination and 
replication. In line with this hypothesis, a common characteristic between HMGA2- [66], ATM- 
[157-159] and H2AX- [160] transgenic mice is genomic instability. In addition, DNA repair 
linked histone modifications H3K56ac and H2Bub1 [161] have been related to transcription 
initiation [162].  
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5.4	Final	Conclusion	
This study demonstrated the role of the HMGA2, a member of HMGA family, as a key regulator 
of lung development and homeostasis by modulating the canonical WNT signaling by several 
lines of evidences.  
This study also deciphered the molecular mechanism responsible for an HMGA2 mediated 
transcriptional activation of Gata6, in which HMGA2 acts as an adaptor to recruit ATM kinase 
on Gata6 promoter for phosphorylation of the linker histone H1 at S65 (H1S65ph) and the core 
histone variant H2AX at S139 (H2AXS139ph). This induces a release of linker Histone H1 from 
the chromatin and subsequently of nucleosomes thereby facilitating the accessibility of 
regulatory elements to transcription initiation factors to enhance transcription of Gata6. 
Furthermore, the sequential order of events was demonstrated in which H1S65ph precedes 
H2AXS139ph and both are a prerequisite for the subsequent disassembly of promoter-associated 
nucleosomes and transcriptional activation. It also showed mutation of H2AX at serine 139 to 
alanine blocks the release of nucleosomes from the chromatin and recruitment of RNA Pol II. 
However, H2AXS139ph is commonly used as a marker for DNA double strand breaks [101] 
suggesting a novel role of this histone modification in transcriptional regulation.   
In summary, this study propose HMGA2 mediated chromatin modulation at the Gata6 promoter, 
as key processes for fine tuning the canonical WNT signaling during lung distal epithelial cell 
differentiation. 
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5.5	Outlook	
In future, it would be interesting to analyze HMGA2 role in the lung injury model systems 
(bleomycin and/or Naphthalene) or in the pneumonectomy model to better understand HMGA2 
role during lung regeneration. 
This study suggests that HMGA2 is required as a regulator of canonical WNT signaling for 
proper lung epithelial cell differentiation. However, it is well known that HMGA2 is positively 
regulated by TGF-β1 signaling [57]. Therefore, Hmga2 might play a crucial role in the interplay 
between these signaling pathways. Hence, it will be of interest to determine a potential opposing 
effect between these two signaling pathways in establishing the proximal-distal axis during 
branching morphogenesis and lung epithelium differentiation in the developing lung.  
HMGA2 is known to activate transcription however, the increased expression of Wnt2b, Wnt7b 
and Wnt11 after Hmga2-/- suggest participation of a transcription inhibitor that could block 
expression of these secreted components of WNT signaling and whose expression could be 
regulated by HMGA2 (Figure 37). Identification of this unknown mediator of HMGA2 will be 
the scope of future studies.   
Milder phenotype observed in the embryonic lung of Hmga2-/- mice when compared with the 
Gata6-/- might be explained by redundancy in the function between Hmga2 and Hmga1, other 
member of the HMGA protein family.  Analysis of the lungs in inducible and conditional double 
transgenic mice (Hmga2−/−:Hmga1−/−) would further test the hypothesis. 
This study established that HMGA2-induced transcriptional activation of Gata6 requires ATM-
mediated phosphorylation of histones and implicates nucleosome eviction. Further studies would 
be carried out to investigate whether the mechanism of Gata6 regulation suggested here might be 
extended to other HMGA2 targets. 
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Chapter 7: APPENDIX 
 
Table 1: List of Primers. Oligonucleotide sequences used for qRT-PCR, ChIP and cloning.  
Gene Primer sequence 
mGata6 Forward  5’ATGGCGTAGAAATGCTGAGGG 
Reverse  5’TGAGGTGGTCGCTTGTGTAG 
mSftpc Forward  5’CGTGGTTGTGGTGGTGGTC 
Reverse  5’GGATGCTCTCTGGAGCCATC 
mFzd2 Forward  5’CCGCTCTTCGTATACCTGTTC 
Reverse  5’CGGATGCGGAAGAGTGACA 
mGapdh Forward  5’TGAGTATGTCGTGGAGTCTAC 
Reverse  5’TGGACTGTGGTCATGAGCC 
mTub1a1 Forward  5’CCGCGAAGCAGCAACCAT 
Reverse  5’CCAGGTCTACGAACACTGCC  
Axin2 Forward  5’GAGTAGCGCCGTGTTAGTGACT 
Reverse  5’CCAGGAAAGTCCGGAAGAGGTATG 
Fgfr2 Forward  5’GCTTCTCAGTGAGTTTTAATAACAGC 
Reverse  5’GAATGATGCTGGGCTTTTGC 
Mycn Forward  5’TGTGTTGACATTAAGAATGTTGGTTTAC 
Reverse  5’TTTCCAAGGTCATGGCAGAAC 
Bmp4 Forward  5’CCCTTTCCACTGGCTGATCA 
Reverse  5’GGGACACAACAGGCCTTAGG 
Wnt 2b Forward  5’TGTGTCAACGCTACCCAGAC 
Reverse  5’TAGCATAGACGAACGCTGCC 
Wnt 11 Forward  5’GCTGCGTCTGGAAGAAGCTAT 
Reverse  5’AGTGGATAGGGAGAGTGCGG 
Wnt7b Forward  5’ GCATCCAAGGTCAACGCAAT 
Reverse  5’CTCAGAGTCTCATGGTCCCTTTG 
Hmga1 Forward  5’CCAGTGAAGTGCCAACTCCGA 
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Reverse  5’CGGCACTGCGAGTGGTGATC 
Scgb1a1 Forward  5’CTGAAGAGACTGGTGGATACC 
Reverse  5’GTTTATTGCAAGAGGAAGGA 
 
hGATA6 
Forward 1 5’CTCGGCTTCTCTCCGCGCCTG 
Reverse 1 5’AGCTGAGGCGTCCCGCAGTTG 
Forward 2 5’GCGGTTTCGTTTTCGGGGAC 
Reverse 2 5’AAGGGATGCGAAGCGTAGGA 
hGAPDH Forward  5’GCAAATTCCATGGCACCGT 
Reverse  5’TCGCCCCACTTGATTTTGG 
hTUB1A1 Forward  5’GAGAGGAGGAGGCACCGAAAA 
Reverse  5’AGGCATTGCCAATCTGGACAC 
 
 
 
 
 
 
mGata6 
(ChIP) 
Forward 1 5’CCCACGACCTGAGCATCCCG 
Reverse 1 5’GAGGGACTCGCCCCCTCCTG 
Forward 2 5’CCAGCTCCTTCCGAGCCAAGT 
Reverse 2 5’GGGGCGCCCAGCTAAAGGAC 
Forward 3 5’CCGGGGTGGACTCGCTCCTA 
Reverse 3 5’GCCAGGCTGTGGGTCGGAAC  
Forward 4 5’ACTCCGGACCAGCCTCCACC 
Reverse 4 5’GCCTCCACCGGGCTGCTTTT 
Forward 5 5’GGACGTGGTTGGACGTGAGG 
Reverse 5 5’CCCGAAAACGAAACCGCCGC 
Forward 6  5’ACGTGCGGAACTCTCTTCACCG 
Reverse 6 5’AGGGTGCCCTCCTCCGTCAC 
Forward 7 5’CCAGCAACTGCAGGACGCCG 
Reverse 7 5’CCCGGCTGGACCACAACAGC 
Forward 8 5’GTGGCTTTCATTGCGCTTCA 
Reverse 8 5’CAGCCCGTTACTGCATGGTA 
 
 
 
Forward 1 5’ATTCCTTGCCCCCTCCCCCG 
Reverse 1 5’TGGGGTGGAGAGGTGCCTTGT 
Forward 2 5’ACCACCACGACCTGAGCCGT 
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hGATA6 
(ChIP) 
Reverse 2 5’TTGGCAGTGCACAGTCCCGC 
Forward 3 5’TTCCCTCCTTCCCTCCGGGC 
Reverse 3 5’TAACTACCGGCTCCCGCCCC 
Forward 4 5’ACGGTCCGGCGTTTCTGCTG 
Reverse 4 5’GGGGCAGCAGTCTGGGTCCT 
Forward 5 5’AGGTGGGGCACTTTCATGTT 
Reverse 5 5’AGAATACCCGGGAGCAGTCA 
 
Hmga2 KO mice 
genotyping 
Forward T 5‘ATTCTGGAGACGCAGGAAGA 
Reverse T 5‘TGCTCCTGGGAGTAGATTGG 
Forward C 5‘CAAATGTTGCTTGTCTGGTG 
Reverse C 5’GTCAGTCGAGTGCACAGTTT 
Hmga2 overexpression 
mice genotyping 
Forward 5'GAGCCAACCTGTGAGCCCT 
Reverse 5'CCTTCCATTCAAAATGTAGGTACTCTGTTC 
mGata6 promoter  
cloning into TOPO TA 
cloning vector 
Forward  5’CCCACGACCTGAGCATCCCG 
Reverse  5’GCCAGGCTGTGGGTCGGAAC  
mHmga2 subcloning 
into pCDNA3.1 (A)-
Myc/His vector 
Forward  5’CACGAATTCAGGAGGTATGAGCGCACGCGG 
Reverse  5’GTGCTCGAGATCCTCCTCTGCGGACTC      
H2AX (S139D)  
point mutation 
Forward  5’GCCACCCAGGCCGACCAGGAGTACTAATCT 
Reverse  5’AGATTAGTACTCCTGGTCGGCCTGGGTGGC 
 
H1(S65A)           
point mutation 
Forward  5’GGTGAGAACGCCGACGCCCAGATCAAGTTG
TCC 
Reverse  5’GGACAACTTGATCTGGGCGTCGGCGTTCTCA
CC 
H1(S65D)           
point mutation 
Forward  5’GGTGAGAACGCCGACGACCAGATCAAGTTG
TCC 
Reverse  5’GGACAACTTGATCTGGTCGTCGGCGTTCTCA
CC 
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Table 2: List of Antibodies 
Antibodies Cat. No. Company WB IF/FACS IP ChIP 
HMGA2 59170AP Biocheck + +   
HMGA2 sc-30223x Santa Cruz  + + + 
TUBA1A T5168 Sigma +    
GATA6 AF1700 R&D system + +   
FZD2 ab52565 Abcam + +   
ABC 05-665 Millipore + +   
CTNNB1 ab6302 Abcam  +   
LRP6 3395 Cell signaling +    
pLRP6 2568 Cell signaling +    
AXIN2 ab32197 Abcam +    
BMP4 4680 Millipore +    
MYCN sc-791 Santa Cruz +    
LMNB1 sc-6216 Santa Cruz + +   
His-tag ab9108 Abcam +    
Myc-tag ab9132 Abcam +    
Flag-tag F1804 Sigma + +   
H1 sc-8030 Santa Cruz  +   + 
ATM sc-23922  Santa Cruz +  + + 
ATMS1981ph sc-47739 Santa Cruz +    
phospho-(Ser/Thr) 
ATM substrate 
2851S Cell Signaling    + + 
H2AX 07-627 Millipore +   + 
H2AXS139ph 05-636 Millipore + +  + 
SCGB1A1 sc-9772 Santa Cruz  +   
CDH1 ab11512 Abcam  +   
VIM-Cy3 C9080 Sigma  +   
PCNA sc7907 Santa Cruz  +   
MKi67 ab15580 Abcam  +   
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pan-cytokeratin C5992 Sigma  +   
Pro-SFTPC AB3786 Millipore  +   
SFTPC sc-7706 Santa cruz  +   
SOX9 sc-17341 Santa Cruz  +   
ACTA2-Cy3 C6198 Sigma  +   
clCASP3 9664S Cell signaling  +   
Pol II ab5408 Abcam    + 
H2B 07-371 Millipore    + 
H3 ab1791 Abcam    + 
H4 05-858 Millipore    + 
rIgG sc-2027 Santa Cruz   + + 
mIgG sc-2025 Santa Cruz   + + 
gIgG sc-2028 Santa Cruz    + 
rIgG-HRP sc-2305 Santa Cruz +    
mIgG-HRP 715-035-150 Jackson Lab +    
gIgG-HRP sc-2020 Santa Cruz +    
gαrAl488 A11008 Invitrogen  +   
gαmAl555 A21422 Invitrogen  +   
dαgAl647 A21447 Invitrogen  +   
dαratCF633A 20137 Biotium  +   
dαrCF488A 20015 Biotium  +   
dαmCF568A 20105 Biotium  +   
Note: Antibody used for specific experiment indicated by ‘+’ sign. 
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Table 3: List of Abbreviations 
Abbreviations Term 
+/+ Wild type 
+/- Heterozygous Knockout 
-/- Homozygous Knockout 
°C Degrees centigrade 
aa Amino acids 
AGE Agarose gel electrophoresis 
ATMS1981ph Phosphorylated ataxia talengiectasia mutated at serine 1981 
ATP Adenosine triphosphate 
AT II Alveolar type II  
BADJ Bronchioalveolar duct junctions 
BASCs Bronchioalveolar stem cells 
BLAST Basic Local Alignment Search Tool 
bp Base pairs 
BRE TFIIB recognition element 
BSA Bovine serum albumin 
cDNA DNA complementary to mRNA 
ChIP Chromatin Immuno-precipitation  
CTRL Control 
DAPI  4’,6-diamidino-2-phenylindole 
DEPC Diethylpyrocarbonate 
dH2O Distilled water 
  
	 APPENDIX	
88
DMEM Dulbecco's Modified Eagle Medium 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
dNTP Deoxyribonucleotide triphosphate 
DPE Downstream promoter elements 
DSB DNA double strand breaks 
DTT Dithiothreitol 
E  embryonic day 
ECL Enhanced chemiluminiscence 
E.coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid 
EGTA Ethylene glycol tetraacetic acid 
EMT Epithelial-Mesenchymal Transformation 
EtBr Ethidium bromide  
FCS Fetal calf serum 
GEO Gene expression omnibus 
GFP Green fluorescence protein 
GO Gene ontology 
GOF Gain of function 
h Hour 
H1S65ph Phosphorylated Histone H1 at serine 65 
H2AXS139ph Phosphorylated Histone H2AX at serine 139 
HEK Human embryonic kidney cell line 
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HMG High mobility group 
HMGA High mobility group AT-hook protein 
INR Initiator sequences 
IP Immuno-precipitation  
ISH In situ hybridization  
KO Homozygous Knockout 
kb Kilo base pairs 
kDa Kilo Dalton 
KEGG Kyoto Encyclopedia of Genes and Genomes 
l  Liter 
LC-MS/MS   Liquid chromatography-mass spectrometry/mass spectrometry 
LOF  Loss of function 
Luc Luciferase 
mg Milligram 
min Minute 
ml Milliliter 
MLE-12 Murine lung epithelial type II cell line-12 
mM   Millimol 
mRNA Messenger RNA 
MW Molecular weight 
NCBI National Center of Biotechnology Information 
nm Nanometer 
P  Postnatal day 
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PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PEEP Positive end-expiratory pressure 
PEI Polyethylenimine  
PFA Paraformaldehyde 
pH Negative logarithm of hydrogen ions concentration 
PMSF Phenylmethanesulfonyl fluoride 
Pol II RNA polymerase II 
qPCR Quantitative Polymerase Chain Reaction  
RNA   Ribonucleic acid 
Rnase Ribonuclease 
rpm Revolutions per minute 
RT Room temperature 
RT-PCR Reverse Transcriptase Polymerase Chain Reaction 
SDS Sodium dodecyl sulphate 
sec Second 
siRNA Short interfering RNA 
SQ Serine-Glutamine amino acid residues 
TAE  Tris-acetate-EDTA 
TBE Tris-borate-EDTA 
TE Tris-EDTA buffer 
TF Transcription factor 
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TGFβ Transforming Growth Factor β 
Tris  Tris-(hydroxymethyl)-aminomethan 
TSS Transcription start site 
U  Unit  
μg  Microgram 
μm Micrometer 
μl Microlitre 
UTR Untranslated region 
UV Ultraviolet 
V Volt 
v/v Volume/volume 
W Watt 
WB Western blot 
w/v Weight/volume 
X-gal 5-bromo-4-chloro-3-indolyl-D-galactopyranoside 
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Table 4: Gene and Protein Nomenclature 
Human Gene Mouse Gene Protein Name 
HMGA2 Hmga2 HMGA2 
GATA6 Gata6 GATA6 
FZD2 Fzd2 FZD2 
LMNB1 Lmnb1 LMNB1 
SFTPC Sftpc SFTPC 
GAPDH Gapdh GAPDH 
TUB1A1 Tub1a1 TUB1A1 
AXIN2 Axin2 AXIN2 
FGFR2 Fgfr2 FGFR2 
MYCN Mycn MYCN 
BMP4 Bmp4 BMP4 
HMGA1 Hmga1 HMGA1 
SCGB1A1 Scgb1a1 SCGb1A1 
WNT2B Wnt2b WNT2B 
WNT11 Wnt11 WNT11 
WNT7B Wnt7b WNT7B 
ATM Atm ATM 
H2AX H2ax H2AX 
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